###begin article-title 0
###xml 60 65 <span type="species:ncbi:9606">human</span>
HMGB1 and HMGB2 proteins up-regulate cellular expression of human topoisomerase IIalpha
###end article-title 0
###begin p 1
###xml 0 16 0 16 <!--CREATIVE COMMONS-->
CREATIVE COMMONSThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License () which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 348 360 336 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 512 524 496 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 706 718 686 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 818 830 794 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 933 945 905 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 1150 1162 1114 1122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 342 347 <span type="species:ncbi:9606">human</span>
###xml 537 542 <span type="species:ncbi:9606">human</span>
Topoisomerase IIalpha (topo IIalpha) is a nuclear enzyme involved in several critical processes, including chromosome replication, segregation and recombination. Previously we have shown that chromosomal protein HMGB1 interacts with topo IIalpha, and stimulates its catalytic activity. Here we show the effect of HMGB1 on the activity of the human topo IIalpha gene promoter in different cell lines. We demonstrate that HMGB1, but not a mutant of HMGB1 incapable of DNA bending, up-regulates the activity of the topo IIalpha promoter in human cells that lack functional retinoblastoma protein pRb. Transient over-expression of pRb in pRb-negative Saos-2 cells inhibits the ability of HMGB1 to activate the topo IIalpha promoter. The involvement of HMGB1 and its close relative, HMGB2, in modulation of activity of the topo IIalpha gene is further supported by knock-down of HMGB1/2, as evidenced by significantly decreased levels of topo IIalpha mRNA and protein. Our experiments suggest a mechanism of up-regulation of cellular expression of topo IIalpha by HMGB1/2 in pRb-negative cells by modulation of binding of transcription factor NF-Y to the topo IIalpha promoter, and the results are discussed in the framework of previously observed pRb-inactivation, and increased levels of HMGB1/2 and topo IIalpha in tumors.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 108 109 108 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 386 387 386 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 616 617 609 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 618 619 611 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 782 783 775 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 1124 1125 1117 1118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 1126 1127 1119 1120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 1128 1129 1121 1122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 700 705 <span type="species:ncbi:9606">human</span>
DNA topoisomerase II (topo II) is an essential and ubiquitous enzyme for proliferation of eukaryotic cells (1). It can alter the topological state of DNA and untangle DNA knots and catenanes (interlocked rings) via ATP-dependent passing of an intact double helix through a transient double-stranded break generated in a separate DNA segment, followed by religation and enzyme turnover (2). In mammalian cells, topo II exists in two isoforms, alpha (170 kDa) and beta (180 kDa), both having similar primary structure and almost identical catalytic properties, but differing in their production during the cell cycle (1,3). Topo II is the target of a number of drugs currently used in the treatment of human malignancies, such as etoposide, teniposide, doxorubicine and mitoxantrone (3). These drugs (also termed topo II poisons) can stabilize the covalent enzyme-associated complexes and shift the DNA cleavage/religation equilibrium of the enzyme reaction toward the cleavage state, converting biological intermediates of topo II activity into lethal ones ultimately leading to triggering of programmed cell death pathways (1,3,4).
###end p 4
###begin p 5
###xml 331 332 331 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 639 642 627 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5 B6 B7 B8">5&#8211;8</xref>
###xml 807 808 795 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 971 972 959 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 973 974 961 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 1249 1253 1237 1241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9 B10 B11 B12">9&#8211;12</xref>
###xml 1322 1323 1310 1311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 1324 1325 1312 1313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 1425 1426 1413 1414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 1427 1429 1415 1417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 1430 1432 1418 1420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 1578 1579 1566 1567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 1805 1807 1793 1795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 2179 2180 2167 2168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 2181 2183 2169 2171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 166 171 <span type="species:ncbi:9606">human</span>
###xml 176 180 <span type="species:ncbi:10090">mice</span>
###xml 252 256 <span type="species:ncbi:10090">mice</span>
###xml 1667 1671 <span type="species:ncbi:10090">mice</span>
###xml 1835 1840 <span type="species:ncbi:10090">mouse</span>
HMGB-type proteins are relatively abundant and evolutionarily highly conserved non-histone chromatin-associated proteins in mammals. There are three HMGB variants in human and mice, HMGB1, HMGB2 and HMGB3. While HMGB1-3 proteins are expressed in early mice embryos, HMGB2 and HMGB3 are down-regulated during embryonic development (5). The abundant HMGB1 protein (approximately1 molecule per 10-15 nucleosomes) is highly conserved among mammals, and it continues to be ubiquitously expressed in adults. HMGB1 and HMGB2 function in a number of fundamental cellular processes such as transcription, replication, DNA repair and recombination (5-8). HMGB1 is associated with chromosomes in mitosis and due to its extreme mobility in the cell the protein is continuously exchanged between nucleus and cytoplasm [(8) and refs therein]. HMGB1, but not HMGB2, also exhibits an important extracellular function in mediation of inflammation mechanisms, tumor growth and metastasis (6,8). HMGB1, like HMGB2-3, has a tripartite domain organization, consisting of two DNA-binding domains, the HMG-boxes A and B, and acidic C-terminal tails of variable length. While the two HMG-boxes interact with DNA (exhibiting a high affinity for distorted DNA conformations (9-12), the C-tail usually decreases the affinity of the protein for DNA (5,7). Binding of HMGB1 to DNA causes local distortions by bending/looping and changes in DNA topology (7,13,14). HMGB1 also interacts weakly with a number of proteins, including transcriptional factors, site-specific recombination and DNA repair proteins (8). The importance of HMGB1 for life is supported by the phenotype of the HMGB1 knockout mice, which die 24 h after birth due to hypoglycemia and exhibit a defect in the transcriptional function of the glucocorticoid receptor (15). Lack of HMGB1 in primary mouse embryonic fibroblasts correlates with higher rates of DNA damage after UV irradiation, and the cytogenetic analyses revealed high levels of aneuploidy and spontaneous chromosome aberrations, decreased activity of telomerase and shortening of telomere lengths, suggesting that HMGB1 plays an important role in promoting genomic stability (5,16).
###end p 5
###begin p 6
###xml 110 112 106 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 241 253 237 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 421 433 413 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 543 545 531 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 616 628 604 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 694 706 678 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 847 859 827 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 1096 1108 1068 1076 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 1317 1319 1281 1283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 235 240 <span type="species:ncbi:9606">human</span>
###xml 415 420 <span type="species:ncbi:9606">human</span>
###xml 446 451 <span type="species:ncbi:9606">human</span>
Previously we have reported that HMGB1 could interact with topo IIalpha and stimulate its enzymatic activity (11). In the present study we studied an impact of over-expression of HMGB1 and its close relative, HMGB2, on the activity of human topo IIalpha promoter. Using luciferase gene reporter assay we have demonstrated that HMGB1, but not a mutant of HMGB1 incapable of DNA bending, up-regulated the activity of human topo IIalpha promoter in human cells that lack functional retinoblastoma protein pRb. Transient over-expression of pRb in Rb-minus cells inhibited the transactivation potential of HMGB1 over the topo IIalpha promoter. In agreement with the above data, up-regulation of the topo IIalpha promoter by HMGB1/2 was very low in cells with functional pRb. The involvement of HMGB1 and HMGB2 in modulation of cellular activity of the topo IIalpha gene was also supported by silencing of HMGB1/2 expression by plasmid-encoded specific shRNA resulting in diminished expression of topo IIalpha. Our experiments allowed us to propose a mechanism of HMGB1-mediated transactivation of the topo IIalpha promoter by modulation of transcriptional factor NF-Y binding to the promoter. The obtained results are discussed in the framework of previously observed increased levels of HMGB1 and topo IIalpha in tumors (17).
###end p 6
###begin title 7
MATERIALS AND METHODS
###end title 7
###begin title 8
Plasmids
###end title 8
###begin p 9
###xml 214 215 214 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 215 218 215 218 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">260</sub>
###xml 219 220 219 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 220 223 220 223 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">280</sub>
Each of the supercoiled DNA plasmids was isolated by alkaline lysis method, followed by purification by two rounds of cesium chloride gradients or by the Qiagen plasmid kits. All purified plasmids exhibited ratios A260/A280 higher than 1.85.
###end p 9
###begin title 10
Antibodies
###end title 10
###begin p 11
###xml 44 50 <span type="species:ncbi:9986">rabbit</span>
###xml 154 159 <span type="species:ncbi:10090">mouse</span>
###xml 174 180 <span type="species:ncbi:9986">rabbit</span>
###xml 214 220 <span type="species:ncbi:9986">rabbit</span>
###xml 268 273 <span type="species:ncbi:10090">mouse</span>
###xml 305 310 <span type="species:ncbi:10090">mouse</span>
###xml 353 359 <span type="species:ncbi:9986">rabbit</span>
Anti-HMGB1 or anti-HMGB2 (affinity purified rabbit polyclonal, BD Pharmingen), alpha-HMGB1 (monoclonal IgG2a, clone #KS1, Stressgen), alpha-topo IIalpha (mouse monoclonal or rabbit polyclonal, Topogen), alpha-pRb (rabbit polyclonal C-15, Santa-Cruz), alpha-pan-actin (mouse monoclonal, Dako), alpha-Flag (mouse monoclonal M2 clone, Sigma), alpha-NF-YB (rabbit polyclonal, a gift from Roberto Mantovani, Italy) or from GeneSpin (PAb001, Milano, Italy).
###end p 11
###begin title 12
DNA circularization assay
###end title 12
###begin p 13
###xml 77 79 77 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 300 303 287 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ava</italic>
###xml 331 334 318 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ava</italic>
###xml 386 388 373 375 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 437 439 420 422 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 750 752 727 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
T4 DNA ligase-mediated circularization was carried out as described earlier (18) with the following modifications. Briefly, ligation was carried out at DNA concentration of approximately1 nM and the concentrations of HMGB1 protein and peptides were 0.5-6 muM. The DNA probe was a gel-purified 123-bp AvaI DNA fragment (prepared by AvaI digestion of the 123-bp DNA lather, BRL) that was 32P-labeled at 5'-ends by T4 DNA kinase and [gamma-32P]ATP (Amersham Biotech). Ligation reactions were initiated by addition of 0.1 U of T4 DNA ligase (Promega) and were allowed to proceed at 30degreesC for 30 min. The ligation products were then deproteinised, followed by their resolution by electrophoresis on 5% polyacrylamide gels in 0.5x TBE as detailed in (19). The amount of monomer DNA circles was determined from quantitative analyses of dried gels on a Molecular Dynamics Storm PhosphorImager using the ImageQuant software.
###end p 13
###begin title 14
Electrophoreic mobility shift experiments (EMSA)
###end title 14
###begin p 15
###xml 54 66 54 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 116 121 112 117 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATTGG</bold>
###xml 151 156 147 152 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCAAT</bold>
###xml 205 210 201 206 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTGGA</bold>
###xml 241 246 237 242 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCCAG</bold>
###xml 294 299 290 295 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATTGG</bold>
###xml 323 328 319 324 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCAAT</bold>
###xml 381 386 377 382 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTGGA</bold>
###xml 414 419 410 415 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCCAG</bold>
###xml 469 474 465 470 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATTGG</bold>
###xml 511 516 507 512 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCAAT</bold>
###xml 566 571 562 567 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTGGA</bold>
###xml 609 614 605 610 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCCAG</bold>
###xml 48 53 <span type="species:ncbi:9606">human</span>
The oligonucleotides for EMSA were derived from human topo IIalpha promoter (5' to 3'): ICE1(WT)-F:CTAGGAGCGAGTCAGGGATTGGCTGGTCTG; ICE1(WT)-R: CAGACCAGCCAATCCCTGACTCGCTCCTAG; ICE1(MUT)-F: CTAGGAGCGAGTCAGGGCTGGACTGGTCTG; ICE1(MUT)-R: CAGACCAGTCCAGCCCTGACTCGCTCCTAG; ICE2(WT)-F: CTAGAAGGCAAGCTACGATTGGTTCTT; ICE2(WT)-R: AAGAACCAATCGTAGCTTGCCTTCTA G-3'; ICE2(MUT)-F: CTAGAAGGCAAGCTACGCTGGATTCTT-3'; ICE2(MUT)-R: AAGAATCCAGCGTAGCTTGCCTTCTAG-3'; ICE3(WT)-F: CTAGCTCCCTAACCTGATTGGTTTATTCAAA-3'; ICE3(WT)-R: TTTGAATAAACCAATCAGGTTAGGGAGCTAG-3'; ICE3(MUT)-F: CTAGCTCCCTAACCTGCTGGATTTATTCAAA-3'; ICE3(MUT)-R: TTTGAATAAATCCAGCAGGTTAGGGAGCTAG-3'.
###end p 15
###begin p 16
###xml 26 28 26 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 86 88 82 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 427 443 420 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 664 666 644 646 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1222 1223 1196 1197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 427 443 <span type="species:ncbi:562">Escherichia coli</span>
The oligonucleotides were 32P-labeled at their 5'-termini by T4 DNA kinase and [gamma-32P]ATP (Amersham Biotech) and annealed with their complementary strands to form blunt-ended DNA duplexes. Reaction mixtures for EMSA contained control nuclear extract (5-10 mug of proteins) or extract pre-incubated with HMGB1 (wild-type or F38A/F103A mutant, typically 1-4 muM) and/or His-pRb(wt) [0.1-0.4 mug, purified from BL21(DE3)pLysS Escherichia coli cells harboring the plasmid pRSET(his-Rb); the plasmid was kindly provided by Ronen Marmorstein from the Wistar Institute, Philadelphia, USA], 1 mug of poly (dI.dC) as a non-specific competitor, and approximately3 ng of 32P-labeled DNA duplexes in EMSA buffer (20 mM HEPES, pH 7.6, 4% Ficoll, 50 mM KCl, 0.1% Nonidet P-40, 0.2 mM EDTA and 0.5 mM DTT) in a total volume of 20 mul. DNA and proteins from nuclear extract were pre-incubated on ice for 20 min. Identity of transcription factor NF-Y within the retarded DNA-protein complexes was verified by pre-incubation of the protein-DNA complexes with 0.5 mug of polyclonal alpha-NF-YB antibodies [kindly provided by Roberto Mantovani, Dipartimento di Scienze Biomolecolari e Biotecnologie, Universita di Milano, Milano, Italy; (9)] at 30degreesC for 20 min. The protein-DNA complexes were resolved on 5% polyacrylamide gels in 0.5x TBE buffer at 200 V for approximately2-3 h (4degreesC). The gels were dried and the labeled DNA was imagined by PhosporImager Storm (Molecular Probes).
###end p 16
###begin title 17
Cloning of HMGB1 plasmids
###end title 17
###begin p 18
###xml 359 362 359 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bam</italic>
###xml 369 372 369 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sal</italic>
###xml 490 497 490 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 856 863 856 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 869 874 869 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HMGB1</italic>
###xml 889 894 889 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HMGB1</italic>
###xml 986 1001 986 1001 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HMGB1 and HMGB2</italic>
###xml 1060 1062 1060 1062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 147 150 <span type="species:ncbi:10116">rat</span>
###xml 154 159 <span type="species:ncbi:9606">human</span>
###xml 204 207 <span type="species:ncbi:10116">rat</span>
###xml 250 255 <span type="species:ncbi:9606">human</span>
###xml 490 497 <span type="species:ncbi:562">E. coli</span>
###xml 856 863 <span type="species:ncbi:562">E. coli</span>
HMGB1 (residues 1-215), HMGB1 domain A (HMG-box A, residues 1-88), HMGB1 domain B (HMG-box B, residues 85-180) and HMGB1 mutants were derived from rat or human HMGB1 cDNAs (the amino-acid sequence of the rat HMGB1 protein is identical to that of the human HMGB1 protein). The DNA sequences coding for the HMGB1 protein, mutants and domains were inserted into BamHI and SalI sites of the vector pQE-80L (Qiagen), which allows tightly regulated N-terminal 6x His-tagged protein expression in E. coli. Alanine mutagenesis of intercalating residues F38, F103 or I122 of isolated HMGB1 domains A or B, and mutagenesis of F38/F103 (double mutant or F/F) of the full-length HMGB1 was carried out by the protocol using 'chimeras' (Stros, unpublished results). The introduced mutations were verified by dideoxi-sequencing of both strands. For protein expression in E. coli, the HMGB1 and truncated HMGB1 cDNAs were re-cloned into the pQE-80L vector (His-tagged proteins). For transfections, the HMGB1 and HMGB2 cDNAs were cloned into the Flag-pcDNA3 or pcDNA3 vectors (20).
###end p 18
###begin title 19
Cell culture
###end title 19
###begin p 20
###xml 40 43 40 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 37 43 37 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>&#8722;/&#8722;</sup></italic>
###xml 47 50 47 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 45 50 45 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb<sup>&#8722;/&#8722;</sup></italic>
###xml 87 90 87 90 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 84 90 84 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>+/+</sup></italic>
###xml 94 97 94 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 92 97 92 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb<sup>+/+</sup></italic>
###xml 148 151 148 151 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 145 151 145 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>&#8722;/&#8722;</sup></italic>
###xml 155 158 155 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 153 158 153 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb<sup>+/+</sup></italic>
###xml 212 215 212 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 209 215 209 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>&#8722;/&#8722;</sup></italic>
###xml 219 222 219 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 217 222 217 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb<sup>&#8722;/&#8722;</sup></italic>
###xml 581 583 581 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 785 786 784 785 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 877 878 875 876 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 300 303 <span type="species:ncbi:9606">man</span>
###xml 766 772 <span type="species:ncbi:9913">bovine</span>
The human osteosarcoma Saos-2 cells (p53-/-, Rb-/-), the breast cancer MCF-7 cells (p53+/+, Rb+/+) and the non-small lung carcinoma H1299 cells (p53-/-, Rb+/+) were grown in 1640 RPMI (Sigma). The 5637 cells (p53-/-, Rb-/-), originally established from the primary bladder carcinoma of a 68-year-old man, was purchased from DSMZ (No: ACC 35). Stable Saos-2 derivatives in which the expression of pRb was controlled by the tetracykline regulated promoter were kindly obtained from Liang Zhu [Department Developmental and Molecular Biology, Albert Einstein College of Medicine, NY; (21)]. The pRb-inducible Saos-2 cells were grown in the presence of 1 mug/ml of tetracycline to prevent pRb expression. All media were supplemented with 10% (v/v) heat-inactivated fetal bovine serum, 2 mM l-glutamine, 100 U/ml penicillin, 100 mug/ml streptomycin, and the cells were grown in 5% C02 at 37degreesC.
###end p 20
###begin title 21
Cell transfections
###end title 21
###begin p 22
Cells were detached by trypsine treatment at 80-90% confluence, and transfected with plasmids either by the use of Amaxa Nucleofector II (Amaxa, Germany) or Fugene HD (Roche). To select for stably transfected cells, Geneticin (BRL) or Zeocin (Invitrogen) were added following 48 h of transfection.
###end p 22
###begin title 23
shRNA-mediated gene silencing of HMGB1 and HMGB2
###end title 23
###begin p 24
###xml 152 157 152 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HMGB1</italic>
###xml 177 184 177 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HMGB1/2</italic>
###xml 47 52 <span type="species:ncbi:9606">human</span>
###xml 209 214 <span type="species:ncbi:9606">human</span>
###xml 538 543 <span type="species:ncbi:9606">human</span>
###xml 575 580 <span type="species:ncbi:9606">human</span>
###xml 616 621 <span type="species:ncbi:9606">human</span>
Plasmid pcDNA-Zeo(-)-U6 under the control of a human U6 promoter was used to express two different short hairpin RNAs (shRNAs) that specifically cleave HMGB1 (construct #A) and HMGB1/2 (construct #B) mRNAs in human cells (the plasmids were kindly provided by Stephen Lippard, Dept. Chemistry, MIT, Cambridge). The following hHMGB1 (#A: GGAGAACATCCTGGCCTGT) or hHMGB2 (#B: AGTGAACACCCTGGCCTAT) sequences were used to create DNA cassettes in pcDNA-Zeo(-)-U6 vector expressing specific shRNAs for silencing of HMGB1 or HMGB1/2 expression in human cells, respectively. Scrambled human HMGB2 sequence (not related to any human sequence) was used as a control (GAGAGGACAAGAGATGTATT). For the purpose of preparation of stably transfected cells, the growth media contained 300 mug/ml Zeocin (Invitrogen) and the cells were selected for 2-3 weeks.
###end p 24
###begin title 25
siRNA-mediated gene silencing of pRb
###end title 25
###begin p 26
###xml 88 90 88 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 93 95 93 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 296 298 295 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
Specific siRNAs for knock-down of pRb in H1299 cells were designed as reported in ref. (44). Rb-positive H1299 cells were transfected with 0.25 mug of either a control duplex siRNA [all sequences were 5'-to-3'; GGGCGUCGAUCCUAACCGGdTdT (top) and CCGGUUAGGAUCGACGCCCdTdT (low)] or a mixture of two Rb-specific siRNA duplexes [#1: GAUACCAGAUCAUGUCAGAdTdT (top) and UCUGACAUGAUCUGGUAUCdTdT (low); #2: CCCAGCAGUUCGAUAUCUAdTdT (top) and UAGAUAUCGAACUGCUGGGdTdT (low); Eurogentec S.A. (Liege)] using the X-tremeGENE siRNA transfection reagent (Roche, Mannheim) as recommended by the manufacturer. For the luciferase gene reporter assays, the corresponding siRNA duplexes were transiently co-transfected with plasmid pTIIalpha-617 and either plasmid pcDNA3 or plasmid pcDNA-HMGB1 as detailed below.
###end p 26
###begin title 27
Luciferase reporter gene assays
###end title 27
###begin p 28
###xml 272 273 272 273 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 732 734 726 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 906 922 897 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Photinus pyralis</italic>
###xml 979 991 970 978 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 1063 1075 1046 1054 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 1306 1308 1285 1287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 1450 1462 1409 1417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 1614 1616 1569 1571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 1812 1817 1763 1768 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GTGGA</bold>
###xml 1866 1872 1817 1823 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCCACC</bold>
###xml 2639 2651 2577 2585 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 2865 2872 2799 2806 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 2941 2948 2874 2881 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 3118 3134 3051 3067 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Photinus pyralis</italic>
###xml 3355 3356 3288 3289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 3597 3608 3530 3538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#946;</italic>
###xml 3703 3719 3633 3649 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Photinus pyralis</italic>
###xml 3775 3786 3705 3713 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#946;</italic>
###xml 514 519 <span type="species:ncbi:9606">human</span>
###xml 906 922 <span type="species:ncbi:7054">Photinus pyralis</span>
###xml 973 978 <span type="species:ncbi:9606">human</span>
###xml 1057 1062 <span type="species:ncbi:9606">human</span>
###xml 1444 1449 <span type="species:ncbi:9606">human</span>
###xml 3118 3134 <span type="species:ncbi:7054">Photinus pyralis</span>
###xml 3591 3596 <span type="species:ncbi:9606">human</span>
###xml 3703 3719 <span type="species:ncbi:7054">Photinus pyralis</span>
###xml 3769 3774 <span type="species:ncbi:9606">human</span>
Transient transfections for luciferease gene reporter assays were carried out in 24-well plates using Fugene HD according to manufacturer instructions (Roche). When using the Amaxa Nucleofector II (Amaxa, Germany), transfections were carried out in six-well plates (2 x 105 cells/well) using the plasmid amounts as indicated below. Transfection mixtures contained Flag-pcDNA3 expression vectors encoding full-length HMGB1 (residues 1-214), HMGB1-DeltaC (residues 1-179) or double-mutant HMGB1 (F38A/F103A), and/or human wild-type pRb [pBC-Rb(379-928)] and mutant pRb [pBC-Rb(379-928), amino-acid 706 C-->F]; [kindly provided by Pradip Raychaudhuri, Department of Biochemistry, College of Medicine, University of Illinois, Chicago; (22)], typically 0.5 mug (Rb) and 2 mug (HMGB1 or HMGB2) of the plasmid DNA. The following reporter constructs (each 0.4 mug) were used: plasmid pGL3-Basic containing firefly Photinus pyralis cDNA (Promega) linked with sequences derived from human topo IIalpha gene promoter: plasmid pTIIalpha-617 containing either wild-type human topo IIalpha promoter or mutated promoter within the ICE2 sequence [the promoter sequences were from bp -617 to +90 and the plasmids were kindly provided by Karin M. Stowell, Institute of Molecular BioSciences, Palmerston North, New Zealand; (23)]; or one of the plasmids pTIIalpha-32, pTIIalpha-90, pTIIalpha-142, pTIIalpha-252 and pTIIalpha-557 containing varying lengths of the human topo IIalpha promoter as indicated [kindly provided by D. Parker Suttle, Department of Pharmacology, College of Medicine, University of Tennessee, Tennessee, USA; (24)]. Mutation of the ICE2 within the plasmid pTIIalpha-142 was carried out by the QuickChange II Site-Directed Mutagenesis Kit (Stratagene) using the following primers: top, 5'-GATATAAAAGGCAAGCTACGGTGGATTCTTCTGGACGGAGACG-3'; low, 5'-CGTCTCCGTCCAGAAGAATCCACCGTAGCTTGCCTTTTATATC-3' (the mutated ICE2 is highlighted). The introduced mutations within the ICE2 (ATTGG mutated to GTGGA) of the topo IIalpha promoter (plasmid pTIIalpha-142_ICE2 mut) were confirmed by dideoxy sequencing. In control luciferase assays, the topo IIalpha promoter-pGL3 constructs were replaced by the empty vector pGL3-Basic. The equal amount of plasmid DNAs in each transfection mixtures was achieved by adding corresponding amounts of empty (promoter-less) plasmid vectors to final 3.6 mug of the transfection mixture when using Amaxa Nucleofector II for transfection. The luciferase activity was measured 40-44 h after transfection using a dual-luciferase reporter assay system (Promega). Results are presented as changes of transactivation of the topo IIalpha promoter constructs relative to the original activity of these promoter constructs in cells not transfected with plasmids expressing (HMGB or pRb) proteins. In some luciferase reporter gene assays, the pRL family Renilla luciferase control reporter vector (0.4 mug) with the cDNA encoding Renilla luciferase under the control of the herpes simplex virus thymidine kinase promoter (pRL-TK, Promega) was used. However, measuring the luciferase activity of the firefly Photinus pyralis proved to be unreliable due to partial activation of the herpes simplex virus thymidine kinase promoter of the pRL-TK by HMGB1/2 [in agreement with reported effects of HMGB1 on transactivation of various gene promoters (8)]. Therefore, the luciferase activity in each cellular lysates was normalized by determining the protein concentrations using the Coomassie G-250 protein-dye assay (Bio-Rad). The involvement of HMGB1/HMGB2 proteins on activity of the human topo IIbeta gene promoter was studied using plasmid -700TOP2B-pGL3 (plasmid pGL3-Basic containing firefly Photinus pyralis cDNA linked with sequence -700 to +193 nt of the human topo IIbeta gene promoter; kindly provided by Susan P.C. Colle (Queen's University, Cancer Research Institute, Division of Cancer Biology & Genetics, Kingston, Canada).
###end p 28
###begin title 29
Quantitative real-time PCR of TOP2A gene
###end title 29
###begin p 30
###xml 34 35 34 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 141 143 141 143 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
###xml 161 166 161 166 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12&#8211;18</sub>
###xml 565 570 562 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TOP2A</italic>
###xml 748 749 745 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 749 750 746 747 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sub>
###xml 780 785 777 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TOP2A</italic>
###xml 820 824 817 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HPRT</italic>
###xml 855 856 852 853 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 856 857 853 854 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sub>
###xml 877 882 874 879 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TOP2A</italic>
###xml 887 891 884 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HPRT</italic>
###xml 908 909 901 902 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 909 910 902 903 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sub>
###xml 940 945 933 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TOP2A</italic>
###xml 974 980 967 969 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#916;</sup>
###xml 980 981 969 970 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</sup>
###xml 980 981 969 970 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>C</sup></italic>
###xml 981 982 970 971 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</sub>
Total RNA was isolated from 2 x 105 Saos-2 cells by RNeasy Mini Kit (Qiagen). First-strand cDNA synthesis was performed using the SuperScriptTM II with oligo(dT)12-18 primer (Invitrogen). Approximatedly five-hundred nanograms of RNA was used for each 20 mul of RT-reaction. Each cDNA sample was analyzed in triplicates using TaqMan(R) Gene Expression Assay (Applied Biosystems) according to manufacturer's instructions. Amplification was detected using 7300 Real Time PCR System (Applied Biosystems). The TaqMan probe used hybridized between exons 10 and 11 of the TOP2A gene. Data were analyzed using Sequence Detection System (SDS) software, version 1.3.1. Results were obtained as the cycle number when the fluorescence reaches a set threshold (CT). The relative expression of TOP2A was quantified as a percentage of HPRT expression. The difference in CT values between the TOP2A and HPRT reactions (DeltaCT) was converted into relative TOP2A expression using a formula 2-DeltaCT x 100%.
###end p 30
###begin title 31
Chromatin immunoprecipitation (ChIP) assays
###end title 31
###begin p 32
###xml 205 206 193 194 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 484 485 460 461 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 786 787 761 762 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w</sub>
###xml 821 823 796 798 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ev</sub>
###xml 904 916 879 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 1112 1113 1082 1083 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1432 1437 1372 1377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GADPH</italic>
###xml 611 617 <span type="species:ncbi:9986">rabbit</span>
###xml 898 903 <span type="species:ncbi:9606">human</span>
###xml 1426 1431 <span type="species:ncbi:9606">human</span>
###xml 1496 1501 <span type="species:ncbi:9606">Human</span>
Stably transfected Saos-2 cells (control or HMGB1/2 silencing; see shRNA-mediated gene silencing of HMGB1 and HMGB2 in the Materials and methods section) were grown to approximately80% confluence in 150 cm2 tissue culture flasks. Cells were then washed in minimal culture medium (without FBS and antibiotics) and fixed with 1% formaldehyde in the same medium on a shaking platform at room temperature for 10 min. Preparation of chromatin and immunoprecipitation (approximately1.5 x 106 cells/reaction) was carried out using the ChiP-IT Enzymatic Express Kit (Active Motif, Rixensart, Belgium). ChIP-grade NF-YB rabbit polyclonal antibody (PAb001 from GeneSpin, Milano, Italy) were at 1 mug/reaction. Purified immunoprecipitated DNA was subjected to semi-quantitative PCR with primers (Fw: 5'-GGTGCCTTTTGAAGCCTCTCTAG-3', Rev: 5'-GCTCCACTTGAACCTTCCTTTAGC-3') specific for a region -215 to -21 of the human topo IIalpha promoter, generating a 195 bp product encompassing three NF-Y-binding sites (ICEs1-3). GoTaq Hot Start DNA polymerase (Promega; 2.5 U/100 mul reaction) was used in 1x Green Flexi buffer/2 mM MgCl2 (Promega). The amplification program consisted of denaturation at 94degreesC for 2 min, followed by 30-34 cycles of 94degreesC for 60 s, 58degreesC for 30 s and 72degreesC for 30 s. As a negative control, 1 mug of control IgG polyclonal antibody (or 1 mug of alpha-RNA pol II antibody using primers specific for human GADPH gene as a positive control) was used (ChIP-IT Control Kit-Human, Active Motif).
###end p 32
###begin title 33
Preparation of nuclear extract
###end title 33
###begin p 34
###xml 59 61 59 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 735 736 731 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 1113 1114 1103 1104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
Nuclear extract was prepared using the published protocol (25) with some modifications. Cells were twice washed with 1x phosphate buffered saline (PBS), trypsinized, followed by washing with 1x PBS containing 10% FCS. After final wash with PBS, the pellet was re-suspended in 1 ml of ice-cold buffer A (10 mM HEPES pH 7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM DTT) containing protease inhibitors (1 mug/ul aprotinin, 10 mug/ul leupeptin, 1 mug/ul pepstatin A, 100 mug/ul trypsin inhibitor, 0.1 mM TLCK and 20 mM benzamidine) and allowed to swell on ice for 15 min. Then 10% Nonidet P-40 was added to final 0.5% and the incubation was continued for more 5 min. Following the incubation, the cellular suspension was spun down (1200 g, 5 min), the nuclei (pellet) were then re-suspended in 1 ml of buffer A (lacking Nonidet P-40), and spun-down as above. The pellet (nuclei) was re-suspended in ice-cold buffer B (20 mM HEPES pH 7.9, 0.4 M NaCl, 1 mM EDTA, 1 mM EGTA) containing protease inhibitors, vortexed for 20 s and rocked at 4degreesC for 30 min. The suspension was clarified by centrifugation (15 000 x g, 10 min) at 4degreesC, and the clear supernatant containing nuclear extract was aliquoted, quick frozen in liquid nitrogen and stored at -70degreesC. For the purpose of the immunoprecipitation, the nuclear extracts were not frozen and used immediately.
###end p 34
###begin title 35
Western blotting and immunological detection of proteins
###end title 35
###begin p 36
###xml 176 182 <span type="species:ncbi:9913">bovine</span>
###xml 485 490 <span type="species:ncbi:9606">human</span>
###xml 746 757 <span type="species:ncbi:3704">horseradish</span>
###xml 785 790 <span type="species:ncbi:10090">mouse</span>
###xml 1107 1111 <span type="species:ncbi:9925">goat</span>
###xml 1117 1123 <span type="species:ncbi:9986">rabbit</span>
###xml 1239 1244 <span type="species:ncbi:10090">mouse</span>
###xml 1344 1355 <span type="species:ncbi:3704">horseradish</span>
###xml 1383 1388 <span type="species:ncbi:10090">mouse</span>
Nuclear extract was prepared from transfected or untransfected cells as above. The protein concentrations were determined by the Bradford Coomassie G-250 assay (Bio-Rad) using bovine serum albumin (BSA) as a standard. Equal amounts of proteins from different nuclear extracts were then separated by SDS-PAGE on SDS/7.5% or 10%-polyacrylamide gels, and the resolved proteins were transferred onto the PVDF membrane (Bio-Rad) using a semi-dry blotting apparatus (Biometra). Detection of human topo IIalpha was carried out by overnight incubation of the membrane with monoclonal anti-topo IIalpha antibody (1:500 dilution, Topogen), followed by extensive washing the membrane in 1x PBS-T (PBS with 0.1% Tween-20) and incubation of the membrane with horseradish peroxidase conjugated anti-mouse antibody (IgG-HRP) (1:2000 dilution, GE Healthcare) for 1 h. Detection of HMGB1 or HMGB2 was carried out by overnight incubation of the membrane with polyclonal alpha-HMGB1 or HMGB2 antibodies (1:500 dilution, BD Pharmingen or Aviva), followed by washing the membrane in 1x PBS-T and incubation of the membrane with goat anti-rabbit IgG-HRP antibody (1:2000 dilution). Equal loading of transferred proteins was verified by detection of actin using mouse monoclonal Pan-actin antibody (Dako, 1:2000 dilution), followed by incubation of the membrane with horseradish peroxidase conjugated anti-mouse antibody (IgG-HRP) (1:2000 dilution, GE Healthcare) as detailed above. Visualization of proteins was performed using West Dura Extended Duration Signal Kit (Pierce). The intensities of signals were quantified using Multi Gauge software of the imaging system LAS-3000 (Fuji).
###end p 36
###begin title 37
Pull-down assays
###end title 37
###begin p 38
###xml 347 349 347 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 556 563 554 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 506 510 <span type="species:ncbi:9913">calf</span>
###xml 533 536 <span type="species:ncbi:10116">rat</span>
###xml 556 563 <span type="species:ncbi:562">E. coli</span>
###xml 1668 1679 <span type="species:ncbi:3704">horseradish</span>
###xml 1707 1713 <span type="species:ncbi:9986">rabbit</span>
Plasmids encoding wild-type pRb (amino-acid residues 379-928) or Rb (C706Y) mutant (aa residues 379-928) fused at the N-terminus with glutathione-S-transferase (GST) were kindly provided by Sybille Mittnacht (Institute of Cancer Research, Chester Beatty Labs, London). GST, GST-pRb and GST-HMGB1 were isolated from BL21(DE3) cells as detailed in (20). GST or GST-tagged pRb (typically 1-2 mug) were bound to glutathione Sepharose 4B beads (40 mul of 1:1 v/v slurry), and incubated with purified HMGB1 from calf thymus or recombinant rat HMGB1 expressed in E. coli (0.5 mug) in buffer PD [20 mM Tris-HCl pH 7.6, 0.2 M NaCl, 10 mM DTT, 0.2% Triton X-100, 0.2% Tween-20, 20% glycerol (v/v), protease inhibitors: 1 mug/ul aprotinin, 10 mug/ul leupeptin, 1 mug/ul pepstatin A, 0.1 mM TLCK and 20 mM benzamidine] by rocking for 2 h at 4degreesC. In some pull-down experiments, GST-tagged HMGB1 or pRb were bound to glutathione Sepharose beads and rotated with nuclear extract from Saos-2 cells in the presence or absence of ethidium bromide (100 mug/ml) at 4degreesC for 2-3 h. After extensive washing of the beads in PD buffer, the proteins associated with the beads were separated on SDS/15% polyacrylamide gels. The proteins were then transferred onto the PVDF membrane by western blotting (as above) and incubated with specific primary antibodies overnight at room temperature. The polyclonal antibodies were: alpha-HMGB1 (1:1000 dilution, BD Pharmingen), alpha-pRb (1:500 dilution; C-15, Santa Cruz), and alpha-NF-YB (1:1000 dilution; a gift from Roberto Mantovani, Italy). Following incubation with the primary antibody, the washed membrane was further incubated with horseradish peroxidase conjugated anti-rabbit antibody (IgG-HRP) (1:2000 dilution, GE Healthcare) for 1 h. Visualization of detected proteins was performed as indicated above.
###end p 38
###begin title 39
Immunoprecipitation of pRb and HMGB1
###end title 39
###begin p 40
###xml 918 919 896 897 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 547 552 <span type="species:ncbi:10090">mouse</span>
###xml 726 732 <span type="species:ncbi:9913">bovine</span>
###xml 1407 1418 <span type="species:ncbi:3704">horseradish</span>
###xml 1446 1452 <span type="species:ncbi:9986">rabbit</span>
Nuclear extract from H1299 cells (0.5 mg per each experiment) was pre-cleared by rotation with 40 microl of protein-A+G (1:1) agarose beads (1:1 v/v slurry) in 1 ml of 1x ECB buffer (0.3 M NaCl, 50 mM HEPES, pH 7.9, 0.2 mM EDTA, 0. 5 mM DTT, 2% Nonidet P-40 plus freshly added protease and phophatase inhibitors) at 4degreesC for 1 h. The beads were removed by centrifugation (10 000 x g for 30 s), the supernatant (pre-cleared nuclear extract) was mixed with 10 mug of monoclonal anti-HMGB1 (IgG2a, clone #KS1, Stressgen) or 10 mug of pre-immune mouse IgG (Sigma), and rotated in 0.5 ml of ECB buffer at 4degreesC for 1 h. Then, 40 microl of pre-cleared 1:1 slurry of protein-A+G agarose beads (pre-incubated with acetylated bovine serum albumin at 0.1 mg/ml in ECB buffer for 1 h, followed by extensive washing in ECB buffer) was added and rotation was continued by more 2 h. The beads were then spin down (10 000 x g for 30 s) and extensively washed (five times) in 1 ml of ECB buffer containing 0.5% Nonidet P-40. The washed beads were then mixed with 20 mul of 10x loading buffer, boiled for 3-4 min and loaded onto SDS/7.5% polyacrylamide gels. The resolved proteins were transferred onto the PVDF membrane (Bio-Rad), and the membrane was incubated with polyclonal alpha-pRb antibody (1:500 dilution; C-15, Santa-Cruz), followed by washing the membrane in 1x PBS-T and incubation of the membrane with horseradish peroxidase conjugated anti-rabbit antibody (IgG-HRP) (1:2000 dilution, GE Healthcare) for 1 h. Visualization of detected proteins was performed by ECL detection kit (GE Healthcare).
###end p 40
###begin title 41
RESULTS
###end title 41
###begin title 42
###xml 19 31 19 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
HMGB1 up-regulates topo IIalpha gene promoter
###end title 42
###begin p 43
###xml 63 75 63 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 219 231 215 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 515 523 499 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 663 671 647 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 870 882 842 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 1010 1022 978 986 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 1064 1076 1028 1036 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 1130 1138 1090 1098 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1290 1299 1250 1259 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1.</label>
###xml 1336 1348 1296 1304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 1360 1361 1316 1317 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1403 1415 1359 1367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 1578 1590 1530 1538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 1648 1660 1592 1600 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 2034 2035 1970 1971 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 2086 2098 2022 2030 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 2195 2207 2127 2135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 2279 2291 2199 2207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 2587 2599 2495 2503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 1299 2895 1259 2797 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="44">HMGB1 up-regulates activity of human <italic>topo II&#945;</italic> promoter. (<bold>A</bold>) Identification of elements within human <italic>topo II&#945;</italic> gene promoter involved in HMGB1-mediated up-regulation of the promoter. Saos-2 cells were co-transfected with the plasmid constructs containing the &#8211;557 bp human <italic>topo II&#945;</italic> promoter (plasmid pTII&#945;-557) or one of the truncated <italic>topo II&#945;</italic> promoter constructs linked to the luciferase reporter gene (as detailed in Materials and methods section), and plasmid encoding HMGB1 (or empty vector). Inset, over-expression of Flag-tagged HMGB1. Lane 1, cells transfected with empty vector; lane 2, cells transfected with plasmid encoding Flag-HMGB1. Immunodetection was carried out using specific &#945;&#8211;HMGB1 antibody. (<bold>B</bold>) Effect of mutation of ICE2 on transactivation of <italic>topo II&#945;</italic> promoter by HMGB1. Saos-2 cells were co-transfected with the plasmids harboring the full-length <italic>topo II&#945;</italic> promoter (plasmids pTII&#945;-617 or pTII&#945;-617_ICE2mt) or truncated <italic>topo II&#945;</italic> promoter (plasmid pTII&#945;-142 or pTII&#945;-142_ICE2mt) containing the wild-type (WT) or mutated ICE2 (ICE2mt), and either empty vector or plasmid encoding HMGB1. Luciferase activity (referred as to transactivation) in panels (A) and (B) is presented relative to the luciferase activity of the <italic>topo II&#945;</italic> promoter in cellular lysates without HMGB1 over-expression (taken as 1). Each transfection experiment was repeated at least five times with triplicate samples. Values are presented as the mean &#177; 1 SD (error bars) of luciferase activities from triplicate samples in a representative experiment.</p>
###xml 1299 2895 1259 2797 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="44">HMGB1 up-regulates activity of human <italic>topo II&#945;</italic> promoter. (<bold>A</bold>) Identification of elements within human <italic>topo II&#945;</italic> gene promoter involved in HMGB1-mediated up-regulation of the promoter. Saos-2 cells were co-transfected with the plasmid constructs containing the &#8211;557 bp human <italic>topo II&#945;</italic> promoter (plasmid pTII&#945;-557) or one of the truncated <italic>topo II&#945;</italic> promoter constructs linked to the luciferase reporter gene (as detailed in Materials and methods section), and plasmid encoding HMGB1 (or empty vector). Inset, over-expression of Flag-tagged HMGB1. Lane 1, cells transfected with empty vector; lane 2, cells transfected with plasmid encoding Flag-HMGB1. Immunodetection was carried out using specific &#945;&#8211;HMGB1 antibody. (<bold>B</bold>) Effect of mutation of ICE2 on transactivation of <italic>topo II&#945;</italic> promoter by HMGB1. Saos-2 cells were co-transfected with the plasmids harboring the full-length <italic>topo II&#945;</italic> promoter (plasmids pTII&#945;-617 or pTII&#945;-617_ICE2mt) or truncated <italic>topo II&#945;</italic> promoter (plasmid pTII&#945;-142 or pTII&#945;-142_ICE2mt) containing the wild-type (WT) or mutated ICE2 (ICE2mt), and either empty vector or plasmid encoding HMGB1. Luciferase activity (referred as to transactivation) in panels (A) and (B) is presented relative to the luciferase activity of the <italic>topo II&#945;</italic> promoter in cellular lysates without HMGB1 over-expression (taken as 1). Each transfection experiment was repeated at least five times with triplicate samples. Values are presented as the mean &#177; 1 SD (error bars) of luciferase activities from triplicate samples in a representative experiment.</p></caption>
###xml 2895 2895 2797 2797 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkp067f1"/>
###xml 1290 2895 1250 2797 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F1" position="float"><label>Figure 1.</label><caption><p textid="44">HMGB1 up-regulates activity of human <italic>topo II&#945;</italic> promoter. (<bold>A</bold>) Identification of elements within human <italic>topo II&#945;</italic> gene promoter involved in HMGB1-mediated up-regulation of the promoter. Saos-2 cells were co-transfected with the plasmid constructs containing the &#8211;557 bp human <italic>topo II&#945;</italic> promoter (plasmid pTII&#945;-557) or one of the truncated <italic>topo II&#945;</italic> promoter constructs linked to the luciferase reporter gene (as detailed in Materials and methods section), and plasmid encoding HMGB1 (or empty vector). Inset, over-expression of Flag-tagged HMGB1. Lane 1, cells transfected with empty vector; lane 2, cells transfected with plasmid encoding Flag-HMGB1. Immunodetection was carried out using specific &#945;&#8211;HMGB1 antibody. (<bold>B</bold>) Effect of mutation of ICE2 on transactivation of <italic>topo II&#945;</italic> promoter by HMGB1. Saos-2 cells were co-transfected with the plasmids harboring the full-length <italic>topo II&#945;</italic> promoter (plasmids pTII&#945;-617 or pTII&#945;-617_ICE2mt) or truncated <italic>topo II&#945;</italic> promoter (plasmid pTII&#945;-142 or pTII&#945;-142_ICE2mt) containing the wild-type (WT) or mutated ICE2 (ICE2mt), and either empty vector or plasmid encoding HMGB1. Luciferase activity (referred as to transactivation) in panels (A) and (B) is presented relative to the luciferase activity of the <italic>topo II&#945;</italic> promoter in cellular lysates without HMGB1 over-expression (taken as 1). Each transfection experiment was repeated at least five times with triplicate samples. Values are presented as the mean &#177; 1 SD (error bars) of luciferase activities from triplicate samples in a representative experiment.</p></caption><graphic xlink:href="gkp067f1"/></fig>
###xml 2895 2904 2797 2806 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2.</label>
###xml 2986 2998 2888 2896 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 3010 3011 2908 2909 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 3838 3839 3735 3736 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 4109 4110 4004 4005 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 4366 4378 4261 4269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 5221 5222 5112 5113 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 5266 5274 5157 5165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 2904 5906 2806 5797 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="45">HMGB1 interacts with transcription factor NF-Y and modulates its binding to human <italic>topo II&#945;</italic> promoter. (<bold>A</bold>) HMGB1 enhances binding of NF-Y to ICE2. Radioactively labeled 30-bp DNA duplex containing ICE2 was mixed with nuclear extract from Saos-2 cells (lane 1) or nuclear extract containing increasing concentrations of HMGB1 (1, 2, 3, 4 and 6 &#956;M, lanes 2-5, respectively), followed by separation of unbound ICE2 DNA duplex (free probe) and DNA&#8211;protein complexes on 5% non-denaturing polyacrylamide gels (EMSA). The presence of NF-Y within the retarded complex (arrow) was verified by super-shifting of the retarded complex (arrow head) with specific polyclonal antibodies against NF-YB. Specificity of NF-Y binding from nuclear extracts to DNA duplexes containing the wild-type ICE2 was also demonstrated by competition experiments with unlabeled DNA duplexes containing the wild-type or mutated sequence of the ICE2 (not shown). (<bold>B</bold>) HMGB1 mutant, incapable of DNA bending, cannot enhance binding of NF-Y to ICEs. EMSA experiment was carried out as in (A). Lane 1, no added HMGB1; lane 2, wild-type HMGB1 (2 &#956;M); lane 3, HMGB1(F38A/F103A), 2 &#956;M. Arrow indicate the mobility of (NF-Y)&#8211;DNA complexes. (<bold>C</bold>) ChIP assays using anti-NF-YB, control IgG antibodies or without antibodies were performed using chromatin from Saos-2 cells (control or upon silencing of HMGB1/2 expression, see Figure 6) as detailed in Materials and methods section. NF-Y binding to the <italic>topo II&#945;</italic> promoter was detected by gel staining (ethidium bromide) after PCR amplification using primers corresponding to the promoter as described in Materials and methods section. For semi-quantitative PCR, amplification reactions were carried out within the linear range of amplification (typically 30&#8211;34 cycles). The ChiP data were calculated as a ratio of PCR signal from ChIPed DNA to the input PCR signal, the final data were obtained from comparison of both cell lines (control or HMGB1/2 sil) and expressed as &#8211;fold change. Control, stably transfected Saos-2 cells (vector); HMGB1/2 sil, stably transfected Saos-2 cells with inhibited HMGB1/2 expression (shRNA-mediated gene silencing of HMGB1/2, Figure 6). The specific PCR product of 195-bp encompassing ICEs 1-3 is indicated by an arrow. M, DNA size marker; ICEs, inverted CCAAT elements. (<bold>D</bold>) Detection of NF-Y binding to HMGB1 or pRb <italic>in vitro</italic>. (Top) Equal amounts of GST, GST-HMGB1 or GST-pRb were immobilized on glutathione Sepharose beads and incubated with nuclear extract from Saos-2 cells. After extensive washings, the resin-bound proteins were eluted and separated by SDS-polyacrylamide gel electrophoresis, followed by W. blotting and immunological detection by anti-NF-YB antibody as detailed in the Material and methods section. EtBr, ethidium bromide. IN, 25% of the nuclear extract from Saos-2 cells used for the &#8216;pull-down&#8217; assay (input). (Bottom) GST or GST-tagged proteins immobilized on agarose beads for the &#8216;pull-down&#8217;assay (Coomassie blue R-250 staining).</p>
###xml 2904 5906 2806 5797 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="45">HMGB1 interacts with transcription factor NF-Y and modulates its binding to human <italic>topo II&#945;</italic> promoter. (<bold>A</bold>) HMGB1 enhances binding of NF-Y to ICE2. Radioactively labeled 30-bp DNA duplex containing ICE2 was mixed with nuclear extract from Saos-2 cells (lane 1) or nuclear extract containing increasing concentrations of HMGB1 (1, 2, 3, 4 and 6 &#956;M, lanes 2-5, respectively), followed by separation of unbound ICE2 DNA duplex (free probe) and DNA&#8211;protein complexes on 5% non-denaturing polyacrylamide gels (EMSA). The presence of NF-Y within the retarded complex (arrow) was verified by super-shifting of the retarded complex (arrow head) with specific polyclonal antibodies against NF-YB. Specificity of NF-Y binding from nuclear extracts to DNA duplexes containing the wild-type ICE2 was also demonstrated by competition experiments with unlabeled DNA duplexes containing the wild-type or mutated sequence of the ICE2 (not shown). (<bold>B</bold>) HMGB1 mutant, incapable of DNA bending, cannot enhance binding of NF-Y to ICEs. EMSA experiment was carried out as in (A). Lane 1, no added HMGB1; lane 2, wild-type HMGB1 (2 &#956;M); lane 3, HMGB1(F38A/F103A), 2 &#956;M. Arrow indicate the mobility of (NF-Y)&#8211;DNA complexes. (<bold>C</bold>) ChIP assays using anti-NF-YB, control IgG antibodies or without antibodies were performed using chromatin from Saos-2 cells (control or upon silencing of HMGB1/2 expression, see Figure 6) as detailed in Materials and methods section. NF-Y binding to the <italic>topo II&#945;</italic> promoter was detected by gel staining (ethidium bromide) after PCR amplification using primers corresponding to the promoter as described in Materials and methods section. For semi-quantitative PCR, amplification reactions were carried out within the linear range of amplification (typically 30&#8211;34 cycles). The ChiP data were calculated as a ratio of PCR signal from ChIPed DNA to the input PCR signal, the final data were obtained from comparison of both cell lines (control or HMGB1/2 sil) and expressed as &#8211;fold change. Control, stably transfected Saos-2 cells (vector); HMGB1/2 sil, stably transfected Saos-2 cells with inhibited HMGB1/2 expression (shRNA-mediated gene silencing of HMGB1/2, Figure 6). The specific PCR product of 195-bp encompassing ICEs 1-3 is indicated by an arrow. M, DNA size marker; ICEs, inverted CCAAT elements. (<bold>D</bold>) Detection of NF-Y binding to HMGB1 or pRb <italic>in vitro</italic>. (Top) Equal amounts of GST, GST-HMGB1 or GST-pRb were immobilized on glutathione Sepharose beads and incubated with nuclear extract from Saos-2 cells. After extensive washings, the resin-bound proteins were eluted and separated by SDS-polyacrylamide gel electrophoresis, followed by W. blotting and immunological detection by anti-NF-YB antibody as detailed in the Material and methods section. EtBr, ethidium bromide. IN, 25% of the nuclear extract from Saos-2 cells used for the &#8216;pull-down&#8217; assay (input). (Bottom) GST or GST-tagged proteins immobilized on agarose beads for the &#8216;pull-down&#8217;assay (Coomassie blue R-250 staining).</p></caption>
###xml 5906 5906 5797 5797 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkp067f2"/>
###xml 2895 5906 2797 5797 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F2" position="float"><label>Figure 2.</label><caption><p textid="45">HMGB1 interacts with transcription factor NF-Y and modulates its binding to human <italic>topo II&#945;</italic> promoter. (<bold>A</bold>) HMGB1 enhances binding of NF-Y to ICE2. Radioactively labeled 30-bp DNA duplex containing ICE2 was mixed with nuclear extract from Saos-2 cells (lane 1) or nuclear extract containing increasing concentrations of HMGB1 (1, 2, 3, 4 and 6 &#956;M, lanes 2-5, respectively), followed by separation of unbound ICE2 DNA duplex (free probe) and DNA&#8211;protein complexes on 5% non-denaturing polyacrylamide gels (EMSA). The presence of NF-Y within the retarded complex (arrow) was verified by super-shifting of the retarded complex (arrow head) with specific polyclonal antibodies against NF-YB. Specificity of NF-Y binding from nuclear extracts to DNA duplexes containing the wild-type ICE2 was also demonstrated by competition experiments with unlabeled DNA duplexes containing the wild-type or mutated sequence of the ICE2 (not shown). (<bold>B</bold>) HMGB1 mutant, incapable of DNA bending, cannot enhance binding of NF-Y to ICEs. EMSA experiment was carried out as in (A). Lane 1, no added HMGB1; lane 2, wild-type HMGB1 (2 &#956;M); lane 3, HMGB1(F38A/F103A), 2 &#956;M. Arrow indicate the mobility of (NF-Y)&#8211;DNA complexes. (<bold>C</bold>) ChIP assays using anti-NF-YB, control IgG antibodies or without antibodies were performed using chromatin from Saos-2 cells (control or upon silencing of HMGB1/2 expression, see Figure 6) as detailed in Materials and methods section. NF-Y binding to the <italic>topo II&#945;</italic> promoter was detected by gel staining (ethidium bromide) after PCR amplification using primers corresponding to the promoter as described in Materials and methods section. For semi-quantitative PCR, amplification reactions were carried out within the linear range of amplification (typically 30&#8211;34 cycles). The ChiP data were calculated as a ratio of PCR signal from ChIPed DNA to the input PCR signal, the final data were obtained from comparison of both cell lines (control or HMGB1/2 sil) and expressed as &#8211;fold change. Control, stably transfected Saos-2 cells (vector); HMGB1/2 sil, stably transfected Saos-2 cells with inhibited HMGB1/2 expression (shRNA-mediated gene silencing of HMGB1/2, Figure 6). The specific PCR product of 195-bp encompassing ICEs 1-3 is indicated by an arrow. M, DNA size marker; ICEs, inverted CCAAT elements. (<bold>D</bold>) Detection of NF-Y binding to HMGB1 or pRb <italic>in vitro</italic>. (Top) Equal amounts of GST, GST-HMGB1 or GST-pRb were immobilized on glutathione Sepharose beads and incubated with nuclear extract from Saos-2 cells. After extensive washings, the resin-bound proteins were eluted and separated by SDS-polyacrylamide gel electrophoresis, followed by W. blotting and immunological detection by anti-NF-YB antibody as detailed in the Material and methods section. EtBr, ethidium bromide. IN, 25% of the nuclear extract from Saos-2 cells used for the &#8216;pull-down&#8217; assay (input). (Bottom) GST or GST-tagged proteins immobilized on agarose beads for the &#8216;pull-down&#8217;assay (Coomassie blue R-250 staining).</p></caption><graphic xlink:href="gkp067f2"/></fig>
###xml 57 62 <span type="species:ncbi:9606">human</span>
###xml 213 218 <span type="species:ncbi:9606">human</span>
###xml 1004 1009 <span type="species:ncbi:9606">human</span>
###xml 1330 1335 <span type="species:ncbi:9606">human</span>
###xml 1397 1402 <span type="species:ncbi:9606">human</span>
###xml 1572 1577 <span type="species:ncbi:9606">human</span>
###xml 2980 2985 <span type="species:ncbi:9606">human</span>
To find out whether HMGB1 could modulate activity of the human topo IIalpha gene promoter, luciferase reporter gene assay was employed by using constructs containing sequences from bp -617 (or -557) to +90 of the human topo IIalpha gene promoter (referred as to the full-length promoter, pTIIalpha-617 or pTIIalpha-557). In some cases, HMGB1 was over-expressed from plasmid encoding the protein fused with a seven amino acids FLAG-tag at the N-terminus to distinguish it on western blots from the endogenous HMGB1 (Figure 1A, inset). However, the luciferase reporter assays using the Flag-tagged and untagged HMGB1 were indistinguishable (not shown). As shown in Figure 1, over-expression of HMGB1 resulted in approximately10-20-fold increase of luciferase activity, depending on individual transfection experiments, rather than on slight differences in the size of the topo IIalpha promoter constructs used (-617 or -557 bp). These findings demonstrated that HMGB1 could up-regulate the activity of the human topo IIalpha promoter, and that the activation of the topo IIalpha promoter increased with the amount of HMGB1 plasmid (Figure 2D; increased levels of ectopically expressed HMGB1 in nuclear lysates were confirmed by immunodetection using specific anti-HMGB1 antibody, not shown). Figure 1.HMGB1 up-regulates activity of human topo IIalpha promoter. (A) Identification of elements within human topo IIalpha gene promoter involved in HMGB1-mediated up-regulation of the promoter. Saos-2 cells were co-transfected with the plasmid constructs containing the -557 bp human topo IIalpha promoter (plasmid pTIIalpha-557) or one of the truncated topo IIalpha promoter constructs linked to the luciferase reporter gene (as detailed in Materials and methods section), and plasmid encoding HMGB1 (or empty vector). Inset, over-expression of Flag-tagged HMGB1. Lane 1, cells transfected with empty vector; lane 2, cells transfected with plasmid encoding Flag-HMGB1. Immunodetection was carried out using specific alpha-HMGB1 antibody. (B) Effect of mutation of ICE2 on transactivation of topo IIalpha promoter by HMGB1. Saos-2 cells were co-transfected with the plasmids harboring the full-length topo IIalpha promoter (plasmids pTIIalpha-617 or pTIIalpha-617_ICE2mt) or truncated topo IIalpha promoter (plasmid pTIIalpha-142 or pTIIalpha-142_ICE2mt) containing the wild-type (WT) or mutated ICE2 (ICE2mt), and either empty vector or plasmid encoding HMGB1. Luciferase activity (referred as to transactivation) in panels (A) and (B) is presented relative to the luciferase activity of the topo IIalpha promoter in cellular lysates without HMGB1 over-expression (taken as 1). Each transfection experiment was repeated at least five times with triplicate samples. Values are presented as the mean +/- 1 SD (error bars) of luciferase activities from triplicate samples in a representative experiment.Figure 2.HMGB1 interacts with transcription factor NF-Y and modulates its binding to human topo IIalpha promoter. (A) HMGB1 enhances binding of NF-Y to ICE2. Radioactively labeled 30-bp DNA duplex containing ICE2 was mixed with nuclear extract from Saos-2 cells (lane 1) or nuclear extract containing increasing concentrations of HMGB1 (1, 2, 3, 4 and 6 muM, lanes 2-5, respectively), followed by separation of unbound ICE2 DNA duplex (free probe) and DNA-protein complexes on 5% non-denaturing polyacrylamide gels (EMSA). The presence of NF-Y within the retarded complex (arrow) was verified by super-shifting of the retarded complex (arrow head) with specific polyclonal antibodies against NF-YB. Specificity of NF-Y binding from nuclear extracts to DNA duplexes containing the wild-type ICE2 was also demonstrated by competition experiments with unlabeled DNA duplexes containing the wild-type or mutated sequence of the ICE2 (not shown). (B) HMGB1 mutant, incapable of DNA bending, cannot enhance binding of NF-Y to ICEs. EMSA experiment was carried out as in (A). Lane 1, no added HMGB1; lane 2, wild-type HMGB1 (2 muM); lane 3, HMGB1(F38A/F103A), 2 muM. Arrow indicate the mobility of (NF-Y)-DNA complexes. (C) ChIP assays using anti-NF-YB, control IgG antibodies or without antibodies were performed using chromatin from Saos-2 cells (control or upon silencing of HMGB1/2 expression, see Figure 6) as detailed in Materials and methods section. NF-Y binding to the topo IIalpha promoter was detected by gel staining (ethidium bromide) after PCR amplification using primers corresponding to the promoter as described in Materials and methods section. For semi-quantitative PCR, amplification reactions were carried out within the linear range of amplification (typically 30-34 cycles). The ChiP data were calculated as a ratio of PCR signal from ChIPed DNA to the input PCR signal, the final data were obtained from comparison of both cell lines (control or HMGB1/2 sil) and expressed as -fold change. Control, stably transfected Saos-2 cells (vector); HMGB1/2 sil, stably transfected Saos-2 cells with inhibited HMGB1/2 expression (shRNA-mediated gene silencing of HMGB1/2, Figure 6). The specific PCR product of 195-bp encompassing ICEs 1-3 is indicated by an arrow. M, DNA size marker; ICEs, inverted CCAAT elements. (D) Detection of NF-Y binding to HMGB1 or pRb in vitro. (Top) Equal amounts of GST, GST-HMGB1 or GST-pRb were immobilized on glutathione Sepharose beads and incubated with nuclear extract from Saos-2 cells. After extensive washings, the resin-bound proteins were eluted and separated by SDS-polyacrylamide gel electrophoresis, followed by W. blotting and immunological detection by anti-NF-YB antibody as detailed in the Material and methods section. EtBr, ethidium bromide. IN, 25% of the nuclear extract from Saos-2 cells used for the 'pull-down' assay (input). (Bottom) GST or GST-tagged proteins immobilized on agarose beads for the 'pull-down'assay (Coomassie blue R-250 staining).
###end p 43
###begin p 44
###xml 37 49 37 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 61 62 57 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 104 116 100 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 279 291 271 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 349 361 333 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 735 736 711 712 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 787 799 763 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 896 908 868 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 980 992 940 948 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 1288 1300 1236 1244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 31 36 <span type="species:ncbi:9606">human</span>
###xml 98 103 <span type="species:ncbi:9606">human</span>
###xml 273 278 <span type="species:ncbi:9606">human</span>
HMGB1 up-regulates activity of human topo IIalpha promoter. (A) Identification of elements within human topo IIalpha gene promoter involved in HMGB1-mediated up-regulation of the promoter. Saos-2 cells were co-transfected with the plasmid constructs containing the -557 bp human topo IIalpha promoter (plasmid pTIIalpha-557) or one of the truncated topo IIalpha promoter constructs linked to the luciferase reporter gene (as detailed in Materials and methods section), and plasmid encoding HMGB1 (or empty vector). Inset, over-expression of Flag-tagged HMGB1. Lane 1, cells transfected with empty vector; lane 2, cells transfected with plasmid encoding Flag-HMGB1. Immunodetection was carried out using specific alpha-HMGB1 antibody. (B) Effect of mutation of ICE2 on transactivation of topo IIalpha promoter by HMGB1. Saos-2 cells were co-transfected with the plasmids harboring the full-length topo IIalpha promoter (plasmids pTIIalpha-617 or pTIIalpha-617_ICE2mt) or truncated topo IIalpha promoter (plasmid pTIIalpha-142 or pTIIalpha-142_ICE2mt) containing the wild-type (WT) or mutated ICE2 (ICE2mt), and either empty vector or plasmid encoding HMGB1. Luciferase activity (referred as to transactivation) in panels (A) and (B) is presented relative to the luciferase activity of the topo IIalpha promoter in cellular lysates without HMGB1 over-expression (taken as 1). Each transfection experiment was repeated at least five times with triplicate samples. Values are presented as the mean +/- 1 SD (error bars) of luciferase activities from triplicate samples in a representative experiment.
###end p 44
###begin p 45
###xml 82 94 82 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 106 107 102 103 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 934 935 929 930 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1205 1206 1198 1199 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1462 1474 1455 1463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 2317 2318 2306 2307 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 2362 2370 2351 2359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 76 81 <span type="species:ncbi:9606">human</span>
HMGB1 interacts with transcription factor NF-Y and modulates its binding to human topo IIalpha promoter. (A) HMGB1 enhances binding of NF-Y to ICE2. Radioactively labeled 30-bp DNA duplex containing ICE2 was mixed with nuclear extract from Saos-2 cells (lane 1) or nuclear extract containing increasing concentrations of HMGB1 (1, 2, 3, 4 and 6 muM, lanes 2-5, respectively), followed by separation of unbound ICE2 DNA duplex (free probe) and DNA-protein complexes on 5% non-denaturing polyacrylamide gels (EMSA). The presence of NF-Y within the retarded complex (arrow) was verified by super-shifting of the retarded complex (arrow head) with specific polyclonal antibodies against NF-YB. Specificity of NF-Y binding from nuclear extracts to DNA duplexes containing the wild-type ICE2 was also demonstrated by competition experiments with unlabeled DNA duplexes containing the wild-type or mutated sequence of the ICE2 (not shown). (B) HMGB1 mutant, incapable of DNA bending, cannot enhance binding of NF-Y to ICEs. EMSA experiment was carried out as in (A). Lane 1, no added HMGB1; lane 2, wild-type HMGB1 (2 muM); lane 3, HMGB1(F38A/F103A), 2 muM. Arrow indicate the mobility of (NF-Y)-DNA complexes. (C) ChIP assays using anti-NF-YB, control IgG antibodies or without antibodies were performed using chromatin from Saos-2 cells (control or upon silencing of HMGB1/2 expression, see Figure 6) as detailed in Materials and methods section. NF-Y binding to the topo IIalpha promoter was detected by gel staining (ethidium bromide) after PCR amplification using primers corresponding to the promoter as described in Materials and methods section. For semi-quantitative PCR, amplification reactions were carried out within the linear range of amplification (typically 30-34 cycles). The ChiP data were calculated as a ratio of PCR signal from ChIPed DNA to the input PCR signal, the final data were obtained from comparison of both cell lines (control or HMGB1/2 sil) and expressed as -fold change. Control, stably transfected Saos-2 cells (vector); HMGB1/2 sil, stably transfected Saos-2 cells with inhibited HMGB1/2 expression (shRNA-mediated gene silencing of HMGB1/2, Figure 6). The specific PCR product of 195-bp encompassing ICEs 1-3 is indicated by an arrow. M, DNA size marker; ICEs, inverted CCAAT elements. (D) Detection of NF-Y binding to HMGB1 or pRb in vitro. (Top) Equal amounts of GST, GST-HMGB1 or GST-pRb were immobilized on glutathione Sepharose beads and incubated with nuclear extract from Saos-2 cells. After extensive washings, the resin-bound proteins were eluted and separated by SDS-polyacrylamide gel electrophoresis, followed by W. blotting and immunological detection by anti-NF-YB antibody as detailed in the Material and methods section. EtBr, ethidium bromide. IN, 25% of the nuclear extract from Saos-2 cells used for the 'pull-down' assay (input). (Bottom) GST or GST-tagged proteins immobilized on agarose beads for the 'pull-down'assay (Coomassie blue R-250 staining).
###end p 45
###begin p 46
###xml 42 54 42 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 151 152 143 144 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</underline>
###xml 160 161 152 153 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</underline>
###xml 166 167 158 159 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</underline>
###xml 173 174 165 166 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">s</underline>
###xml 180 181 172 173 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</underline>
###xml 191 193 183 185 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TF</underline>
###xml 326 328 314 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 331 339 319 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 377 389 365 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 597 609 581 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 1066 1068 1034 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 1099 1111 1067 1075 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 1255 1267 1215 1223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 1283 1291 1239 1247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1353 1365 1301 1309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 1524 1525 1464 1465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 1526 1527 1466 1467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 1528 1530 1468 1470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 1631 1643 1571 1579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 1844 1856 1780 1788 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 1889 1897 1817 1825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 2005 2013 1933 1941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 2078 2090 2006 2014 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 2225 2233 2145 2153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 2346 2358 2266 2274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 2470 2482 2386 2394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 371 376 <span type="species:ncbi:9606">human</span>
###xml 2340 2345 <span type="species:ncbi:9606">human</span>
The known regulatory elements of the -557 topo IIalpha gene promoter (pTIIalpha-557) construct involve five inverted CCAAT boxes (referred as to ICEs, Inverted CCAAT Elements), an Activating TF-binding site (ATF), and one GC1 box (the second GC box, GC2, is present only within the -pTIIalpha-617) and no functional TATA box (26), Figure 1A. To identify sequences of the human topo IIalpha promoter involved in HMGB1-mediated up-regulation of the promoter, Saos-2 cells were co-transfected with the HMGB1 expression plasmid and the luciferase reporter constructs containing varying lengths of the topo IIalpha gene promoter. Deletions of the sequences from bp -557 to -142 (encompassing ICE5, ICE4, ICE3 and ATF) had very little, if any, effect on the ability of HMGB1 to up-regulate the activity of the promoter [albeit stepwise deletion of the 5'-promoter sequences from bp -557 to -142 of the full promoter resulted in up to approximately20-fold decrease in luciferase activity in the absence of over-expressed HMGB1, in agreement with previously published data (24)]. However, truncation of the topo IIalpha promoter from bp -142 to -90 including the ICE2 (pTIIalpha-90 containing only ICE1) markedly decreased the ability of HMGB1 to up-regulate the topo IIalpha gene promoter (Figure 1A, pTIIalpha-142 or pTIIalpha-90). A slight activation of the topo IIalpha promoter lacking all known regulatory sequences (pTIIalpha-32) by HMGB1 was to be explained by the reported effect of the protein on the basal transcription (5,8,27). The above data suggested the importance of the ICE2 for the HMGB1-mediated transactivation of the topo IIalpha promoter. The latter conclusion seemed to be confirmed by mutation of the ICE2 (ATTGG mutated to GTGGA) within the -142 promoter construct resulting in inability of HMGB1 to transactivate the -142 bp topo IIalpha promoter (pTIIalpha-142_ICE2mt, Figure 1B, right). However, while the ICE2 was crucial for the HMGB1-mediated transactivation of the -142 promoter (Figure 1A), it was much less important in the context of the full-length topo IIalpha promoter as revealed by the luciferase gene reporter assay using the -617 promoter construct with mutated ICE2 (pTIIalpha-617_ICE2mt, Figure 1B, left). These results questioned the central role of the ICE2 in the HMGB1-mediated up-regulation of the human topo IIalpha promoter, and pointed out the possible importance of multiple ICEs for the HMGB1-mediated up-regulation of the topo IIalpha promoter (see Discussion section).
###end p 46
###begin p 47
###xml 410 411 410 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 412 413 412 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 414 415 414 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 647 659 647 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 666 668 662 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 669 671 665 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 857 859 853 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 969 981 961 969 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 1036 1038 1024 1026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 1039 1041 1027 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 1042 1044 1030 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 1101 1113 1089 1097 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 1453 1465 1437 1445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 1597 1605 1565 1573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 243 248 <span type="species:ncbi:9606">human</span>
###xml 641 646 <span type="species:ncbi:9606">human</span>
###xml 826 831 <span type="species:ncbi:9606">human</span>
###xml 907 912 <span type="species:ncbi:9606">human</span>
###xml 1447 1452 <span type="species:ncbi:9606">human</span>
It is generally assumed that HMGB1 could facilitate binding of a number of transcription factors (such as steroid hormone receptors, homeitic HOX proteins, recombination activating gene protein RAG1, octamer transcription factors Oct-1/Oct-2, human TATA-binding protein TBP, TFIID and proteins of p53 family) to their cognate sites by binding to the TFs and delivering them to the corresponding DNA sequences (5,7,8). NF-Y (nuclear factor-Y) is a transcription factor comprising NF-YA, NF-YB, and NF-YC subunits. NF-Y specifically recognizes a CCAAT box motif which is found in the promoter and enhancer regions of many genes, including the human topo IIalpha gene (26,29). The NF-YA subunit associates only with the NF-YB:NF-YC heterodimer creating a functional NF-Y (trimer) CCAAT box DNA-binding complex. NF-Y binds to the human ICE1-4, but not to ICE5 (30). The effect of NF-Y on cellular levels of the human topo IIalpha (and subsequently on the regulation of the topo IIalpha gene promoter) is elusive due to conflicting reports (23,31,32). Thus, a simple explanation for the enhancement of the topo IIalpha promoter activity by HMGB1 could be that HMGB1 could promote binding of crucial activators, such as NF-Y, to their DNA-binding sites. Electrophoretic Mobility Shift Assay (EMSA) was therefore used to determine whether HMGB1 could enhance binding of NF-Y to short DNA duplexes containing ICE1, ICE2 or ICE3 sequences derived from the human topo IIalpha promoter. Addition of HMGB1 to nuclear lysate from Saos-2 cells could enhance (approximately2-3-fold) binding of NF-Y to the ICE2 (Figure 2A), and also to the ICE1 and ICE3 (data not shown), demonstrating the ability of HMGB1 to promote NF-Y binding to various ICEs.
###end p 47
###begin p 48
###xml 32 40 32 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 109 117 109 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 193 205 193 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 220 227 216 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 293 305 289 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 710 722 702 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 822 830 810 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 969 981 945 953 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 1110 1122 1082 1090 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 1132 1139 1100 1107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 187 192 <span type="species:ncbi:9606">human</span>
###xml 704 709 <span type="species:ncbi:9606">human</span>
###xml 1104 1109 <span type="species:ncbi:9606">human</span>
The ability of HMGB1 to promote in vitro binding of NF-Y to DNA duplexes containing inverted CCAAT elements (Figure 2A) could indicate that the protein could modulate NF-Y binding to the human topo IIalpha gene promoter in vivo. To find out whether HMGB1/2 could affect binding of NF-Y to the topo IIalpha promoter, chromatin immunoprecipitation (ChIP) was used. For this purpose, control Saos-2 cells and cells with inhibited HMGB1/2 expression were fixed with formaldehyde, chromatin sheared by enzymatic digestion and immunoprecipitated with anti-NF-YB or control antibodies. Purified immunoprecipitated DNA was subjected to semi-quantitative PCR with primers specific for a region -215 to -21 of the human topo IIalpha promoter, amplifying a 195 bp product encompassing three NF-Y-binding sites (ICEs1-3). As shown in Figure 2C, the ChIP analysis revealed that inhibition of HMGB1/2 expression resulted in up to approximately3-fold reduction in NF-Y binding to the topo IIalpha gene promoter relative to the control cells. These data provided evidence that HMGB1/2 could modulate NF-Y binding to the human topo IIalpha promoter in vivo.
###end p 48
###begin p 49
###xml 52 60 52 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 392 400 392 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 617 625 617 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 981 989 981 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1071 1083 1071 1079 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 1099 1107 1095 1103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
To find out whether HMGB1 could interact with NF-Y, in vitro 'pull-down' (PD) assay was used. GST or GST-HMGB1 were immobilized on glutathione Sepharose beads and incubated with nuclear extract from Saos-2 cells. After extensive washings, the resin-bound proteins were separated by electrophoresis, followed by western blotting and immunological detection by anti-NF-YB antibody. As shown in Figure 2D (top), a significant fraction of NF-YB was found to be associated with HMGB1 relative to control GST-bound beads (equal amounts of GST or GST-HMGB1 immobilized on agarose beads were verified by gel electrophoresis, Figure 2D, bottom). Interaction between HMGB1 and NF-Y was not facilitated via DNA as similar results were obtained from PD assay in the presence of DNA intercalator ethidium bromide. The above results demonstrated the ability of HMGB1 to interact with NF-Y, and provided a possible explanation for the observed HMGB1-mediated enhancement of NF-Y binding to ICEs (Figure 2A), a basis for understanding of the effect of the protein on the activity of the topo IIalpha gene promoter (Figure 1).
###end p 49
###begin title 50
###xml 82 94 82 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
Intercalating residues of HMGB1 are required for DNA bending and up-regulation of topo IIalpha gene promoter
###end title 50
###begin p 51
###xml 45 67 45 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sacharomyces cerevisae</italic>
###xml 80 103 80 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila melanogaster</italic>
###xml 254 256 254 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 257 259 257 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 416 424 416 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 833 842 821 830 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3.</label>
###xml 914 926 902 910 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 943 944 927 928 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1044 1045 1028 1029 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1316 1317 1300 1301 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1324 1325 1308 1309 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1544 1545 1524 1525 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1729 1731 1709 1711 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 2232 2233 2205 2206 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 2258 2270 2231 2239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 2506 2514 2467 2475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 842 2515 830 2476 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="52">HMGB1 incapable of DNA bending cannot up-regulate activity of human the <italic>topo II&#945;</italic> gene promoter. (<bold>A</bold>) Position of intercalating residues within the HMGB1 domains A (Phe38) and B (Phe103 and Ile122). (<bold>B</bold>) Purity of HMGB1, domains A and B, and mutants as revealed by electrophoresis on an SDS/18% polyacrylamide gel and Coomassie blue R-250 staining. Lane 1, wild-type HMGB1; lane 2, HMGB1(F38A); lane 3, HMGB1(F103A); lane 4, HMGB1(F38A/F103A) [designated as F/F in panels (<bold>C</bold>) and (<bold>D</bold>)]; lane 5, HMGB1 lacking the C-tail (HMGB1-&#916;C or A+B di-domain); lane 6, the wild-type domain A; lane 7, domain A (F38A); lane 8, the wild-type domain B; lane 9, domain B (F103A); lane 10, domain B (F103A/I122A). (<bold>C</bold>) Effect of mutated intercalating amino acids of HMGB1 or HMGB1 domains A and B on T4 DNA ligase-mediated DNA cyclization. Ligase-mediated circularization assay was carried out with a <sup>32</sup>P-labeled 123-bp DNA duplex, and HMGB1 or HMGB1-&#916;C at concentrations of 0.05, 1 and 1.5 &#956;M (left to right, upper panel). For experiments with individual HMGB1 domains, the concentrations of the domain A or mutants were 1.5, 3 and 6 &#956;M, and the concentrations of the domain B or mutants were 0.5, 1 and 1.5 &#956;M (left to right, lower panel). The DNA&#8211;protein complexes were ligated with T4 DNA ligase and the deproteinised DNA samples were then separated on 5% non-denaturing polyacrylamide gels. (<bold>D</bold>) Transactivation of the <italic>topo II&#945;</italic> gene promoter by the double-mutant of HMGB1 or HMGB1-&#916;C. Plasmids encoding HMGB1 or mutants were co-transformed with the plasmid pTII&#945;-617 into the Saos-2 cells, and the luciferase activity (transactivation) was measured as in <xref ref-type="fig" rid="F1">Figure 1</xref>.</p>
###xml 842 2515 830 2476 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="52">HMGB1 incapable of DNA bending cannot up-regulate activity of human the <italic>topo II&#945;</italic> gene promoter. (<bold>A</bold>) Position of intercalating residues within the HMGB1 domains A (Phe38) and B (Phe103 and Ile122). (<bold>B</bold>) Purity of HMGB1, domains A and B, and mutants as revealed by electrophoresis on an SDS/18% polyacrylamide gel and Coomassie blue R-250 staining. Lane 1, wild-type HMGB1; lane 2, HMGB1(F38A); lane 3, HMGB1(F103A); lane 4, HMGB1(F38A/F103A) [designated as F/F in panels (<bold>C</bold>) and (<bold>D</bold>)]; lane 5, HMGB1 lacking the C-tail (HMGB1-&#916;C or A+B di-domain); lane 6, the wild-type domain A; lane 7, domain A (F38A); lane 8, the wild-type domain B; lane 9, domain B (F103A); lane 10, domain B (F103A/I122A). (<bold>C</bold>) Effect of mutated intercalating amino acids of HMGB1 or HMGB1 domains A and B on T4 DNA ligase-mediated DNA cyclization. Ligase-mediated circularization assay was carried out with a <sup>32</sup>P-labeled 123-bp DNA duplex, and HMGB1 or HMGB1-&#916;C at concentrations of 0.05, 1 and 1.5 &#956;M (left to right, upper panel). For experiments with individual HMGB1 domains, the concentrations of the domain A or mutants were 1.5, 3 and 6 &#956;M, and the concentrations of the domain B or mutants were 0.5, 1 and 1.5 &#956;M (left to right, lower panel). The DNA&#8211;protein complexes were ligated with T4 DNA ligase and the deproteinised DNA samples were then separated on 5% non-denaturing polyacrylamide gels. (<bold>D</bold>) Transactivation of the <italic>topo II&#945;</italic> gene promoter by the double-mutant of HMGB1 or HMGB1-&#916;C. Plasmids encoding HMGB1 or mutants were co-transformed with the plasmid pTII&#945;-617 into the Saos-2 cells, and the luciferase activity (transactivation) was measured as in <xref ref-type="fig" rid="F1">Figure 1</xref>.</p></caption>
###xml 2515 2515 2476 2476 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkp067f3"/>
###xml 833 2515 821 2476 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F3" position="float"><label>Figure 3.</label><caption><p textid="52">HMGB1 incapable of DNA bending cannot up-regulate activity of human the <italic>topo II&#945;</italic> gene promoter. (<bold>A</bold>) Position of intercalating residues within the HMGB1 domains A (Phe38) and B (Phe103 and Ile122). (<bold>B</bold>) Purity of HMGB1, domains A and B, and mutants as revealed by electrophoresis on an SDS/18% polyacrylamide gel and Coomassie blue R-250 staining. Lane 1, wild-type HMGB1; lane 2, HMGB1(F38A); lane 3, HMGB1(F103A); lane 4, HMGB1(F38A/F103A) [designated as F/F in panels (<bold>C</bold>) and (<bold>D</bold>)]; lane 5, HMGB1 lacking the C-tail (HMGB1-&#916;C or A+B di-domain); lane 6, the wild-type domain A; lane 7, domain A (F38A); lane 8, the wild-type domain B; lane 9, domain B (F103A); lane 10, domain B (F103A/I122A). (<bold>C</bold>) Effect of mutated intercalating amino acids of HMGB1 or HMGB1 domains A and B on T4 DNA ligase-mediated DNA cyclization. Ligase-mediated circularization assay was carried out with a <sup>32</sup>P-labeled 123-bp DNA duplex, and HMGB1 or HMGB1-&#916;C at concentrations of 0.05, 1 and 1.5 &#956;M (left to right, upper panel). For experiments with individual HMGB1 domains, the concentrations of the domain A or mutants were 1.5, 3 and 6 &#956;M, and the concentrations of the domain B or mutants were 0.5, 1 and 1.5 &#956;M (left to right, lower panel). The DNA&#8211;protein complexes were ligated with T4 DNA ligase and the deproteinised DNA samples were then separated on 5% non-denaturing polyacrylamide gels. (<bold>D</bold>) Transactivation of the <italic>topo II&#945;</italic> gene promoter by the double-mutant of HMGB1 or HMGB1-&#916;C. Plasmids encoding HMGB1 or mutants were co-transformed with the plasmid pTII&#945;-617 into the Saos-2 cells, and the luciferase activity (transactivation) was measured as in <xref ref-type="fig" rid="F1">Figure 1</xref>.</p></caption><graphic xlink:href="gkp067f3"/></fig>
###xml 80 103 <span type="species:ncbi:7227">Drosophila melanogaster</span>
###xml 141 146 <span type="species:ncbi:9606">human</span>
###xml 464 469 <span type="species:ncbi:9606">human</span>
###xml 904 909 <span type="species:ncbi:9606">human</span>
Previous experiments with HMGB proteins from Sacharomyces cerevisae (NHP6A) and Drosophila melanogaster (HMG-D), which are highly related to human HMGB1 protein, revealed that mutation of DNA intercalating residues impaired their DNA-bending properties (33,34). Using ligase-mediated circularization assay we have studied whether the intercalating residues (Phe38 of the domain A, and Phe103/Ile122 of the domain B, Figure 3A) are also required for DNA bending by human HMGB1. This assay measures the efficiency with which T4 DNA ligase forms minicircles from fragments of DNA that are shorter than approximately150 bp. In the absence of internal curvature, the stiffness of a short DNA fragment (<150 bp) prevents intra-molecular alignment of its ends so that minicircles are detected only in the presence a protein that bends DNA. Figure 3.HMGB1 incapable of DNA bending cannot up-regulate activity of human the topo IIalpha gene promoter. (A) Position of intercalating residues within the HMGB1 domains A (Phe38) and B (Phe103 and Ile122). (B) Purity of HMGB1, domains A and B, and mutants as revealed by electrophoresis on an SDS/18% polyacrylamide gel and Coomassie blue R-250 staining. Lane 1, wild-type HMGB1; lane 2, HMGB1(F38A); lane 3, HMGB1(F103A); lane 4, HMGB1(F38A/F103A) [designated as F/F in panels (C) and (D)]; lane 5, HMGB1 lacking the C-tail (HMGB1-DeltaC or A+B di-domain); lane 6, the wild-type domain A; lane 7, domain A (F38A); lane 8, the wild-type domain B; lane 9, domain B (F103A); lane 10, domain B (F103A/I122A). (C) Effect of mutated intercalating amino acids of HMGB1 or HMGB1 domains A and B on T4 DNA ligase-mediated DNA cyclization. Ligase-mediated circularization assay was carried out with a 32P-labeled 123-bp DNA duplex, and HMGB1 or HMGB1-DeltaC at concentrations of 0.05, 1 and 1.5 muM (left to right, upper panel). For experiments with individual HMGB1 domains, the concentrations of the domain A or mutants were 1.5, 3 and 6 muM, and the concentrations of the domain B or mutants were 0.5, 1 and 1.5 muM (left to right, lower panel). The DNA-protein complexes were ligated with T4 DNA ligase and the deproteinised DNA samples were then separated on 5% non-denaturing polyacrylamide gels. (D) Transactivation of the topo IIalpha gene promoter by the double-mutant of HMGB1 or HMGB1-DeltaC. Plasmids encoding HMGB1 or mutants were co-transformed with the plasmid pTIIalpha-617 into the Saos-2 cells, and the luciferase activity (transactivation) was measured as in Figure 1.
###end p 51
###begin p 52
###xml 72 84 72 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 101 102 97 98 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 202 203 198 199 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 474 475 470 471 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 482 483 478 479 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 702 703 694 695 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 887 889 879 881 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1390 1391 1375 1376 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1416 1428 1401 1409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 1664 1672 1637 1645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 62 67 <span type="species:ncbi:9606">human</span>
HMGB1 incapable of DNA bending cannot up-regulate activity of human the topo IIalpha gene promoter. (A) Position of intercalating residues within the HMGB1 domains A (Phe38) and B (Phe103 and Ile122). (B) Purity of HMGB1, domains A and B, and mutants as revealed by electrophoresis on an SDS/18% polyacrylamide gel and Coomassie blue R-250 staining. Lane 1, wild-type HMGB1; lane 2, HMGB1(F38A); lane 3, HMGB1(F103A); lane 4, HMGB1(F38A/F103A) [designated as F/F in panels (C) and (D)]; lane 5, HMGB1 lacking the C-tail (HMGB1-DeltaC or A+B di-domain); lane 6, the wild-type domain A; lane 7, domain A (F38A); lane 8, the wild-type domain B; lane 9, domain B (F103A); lane 10, domain B (F103A/I122A). (C) Effect of mutated intercalating amino acids of HMGB1 or HMGB1 domains A and B on T4 DNA ligase-mediated DNA cyclization. Ligase-mediated circularization assay was carried out with a 32P-labeled 123-bp DNA duplex, and HMGB1 or HMGB1-DeltaC at concentrations of 0.05, 1 and 1.5 muM (left to right, upper panel). For experiments with individual HMGB1 domains, the concentrations of the domain A or mutants were 1.5, 3 and 6 muM, and the concentrations of the domain B or mutants were 0.5, 1 and 1.5 muM (left to right, lower panel). The DNA-protein complexes were ligated with T4 DNA ligase and the deproteinised DNA samples were then separated on 5% non-denaturing polyacrylamide gels. (D) Transactivation of the topo IIalpha gene promoter by the double-mutant of HMGB1 or HMGB1-DeltaC. Plasmids encoding HMGB1 or mutants were co-transformed with the plasmid pTIIalpha-617 into the Saos-2 cells, and the luciferase activity (transactivation) was measured as in Figure 1.
###end p 52
###begin p 53
###xml 39 47 39 47 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 128 135 128 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 170 178 170 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 418 419 418 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 420 422 420 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 423 425 423 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 426 428 426 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 429 431 429 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 494 502 494 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 1320 1328 1320 1328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 1601 1603 1601 1603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 1643 1645 1643 1645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 1646 1648 1646 1648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 1868 1876 1864 1872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 2088 2090 2084 2086 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 2091 2093 2087 2089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 2094 2096 2090 2092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 2097 2099 2093 2095 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 2100 2102 2096 2098 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B56">56</xref>
###xml 128 135 <span type="species:ncbi:562">E. coli</span>
HMGB1 and individual domains, A and B (Figure 3A), have been mutated by alanine mutagenesis, and the proteins were expressed in E. coli and purified to near homogeneity (Figure 3B). To understand the importance of individual intercalating amino acids of HMGB1 for the ability of the protein to bend DNA, single HMG-boxes, domains A and B, and their mutants were first investigated. In agreement with previous studies (9,10,18,35,36), the domain B seemed to be more efficient than the domain A (Figure 3C, lower panel). Mutation of Phe38 (domain A) or Phe103 (domain B) to alanine completely abolished the ability of the both single domains to form DNA minicircles. On the other hand, mutation of the second intercalating residue of domain B, Ile122, had only a little effect on the ability of the domain to bend DNA. Interesting results were obtained upon mutagenesis of the intercalating residues in the context of the full-length HMGB1. Whereas mutation of Phe38 (domain A) exhibited only a little effect on the ability of the HMGB1 protein to bend DNA, mutation of Phe103 (domain B) nearly abrogated the ability of the protein to bend DNA. A complete inhibition of the ability of HMGB1 to bend DNA was to be achieved only when both intercalating phenylalanine residues, Phe38 and Phe103, had been mutated to alanine (Figure 3C, a double mutant F38/F103, upper panel). These results indicated that the domain B could largely substitute for the DNA-bending potential of the domain A within the full-length HMGB1, suggesting the major role of the domain B in mediating DNA bending by HMGB1 [see also (37)]. In agreement with previous studies (18,36), the DNA-bending potential of the two HMG-box domains of HMGB1 was down-regulated by its acidic C-tail as revealed by enhanced formation of minicircles by HMGB1 lacking the acidic C-tail (referred as to HMGB1-DeltaC), Figure 3C (upper panel). We have found that single or multiple alanine mutagenesis of Phe38 and Phe103 had only a relative small effect on the binding properties of the full-length HMGB1 protein to linear DNA [see also (12,34,38,39,56)].
###end p 53
###begin p 54
###xml 116 128 116 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 298 306 290 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 399 411 387 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 615 627 575 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 787 789 739 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 790 792 742 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 793 795 745 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 796 798 748 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 856 868 808 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 879 887 827 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 955 963 903 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 1280 1288 1228 1236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 110 115 <span type="species:ncbi:9606">human</span>
In order to find out whether the ability of HMGB1 to bend DNA was essential for the observed up-regulation of human topo IIalpha promoter, the impact of over-expression of either HMGB1 lacking the acidic C-tail (HMGB1-DeltaC) or a double mutant HMGB1(F38A/F103A) has been investigated. As shown in Figure 3D, over-expression of HMGB1-DeltaC in Saos-2 cells resulted in higher transactivation of the topo IIalpha promoter than that by the full-length HMGB1 (approximately30-fold and approximately20-fold, respectively), suggesting that the acidic C-tail of HMGB1 inhibited the ability of the protein to activate the topo IIalpha promoter. The higher transactivation potential of HMGB1-DeltaC was consistent with reported enhanced DNA-bending and -binding properties of the A+B di-domain (14,18,35,37). The inability of the HMGB1 mutant to transactivate the topo IIalpha promoter (Figure 3D) may be related to impaired DNA-bending properties of the mutant (Figure 3C, top; similar levels of ectopically expressed HMGB1 and mutants were verified by gel electrophoresis and immunodetection using specific antibodies, not shown). The latter idea was in agreement with the EMSA experiments demonstrating that HMGB1 incapable of DNA bending could no longer enhance NF-Y binding to ICEs (Figure 2B).
###end p 54
###begin title 55
###xml 17 29 17 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
Up-regulation of topo IIalpha gene promoter by HMGB1 is inhibited by retinoblastoma protein pRb
###end title 55
###begin p 56
###xml 67 79 67 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 134 137 130 133 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 140 143 136 139 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 131 143 127 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>&#8722;/&#8722;</sup>/Rb<sup>&#8722;/&#8722;</sup></italic>
###xml 250 253 246 249 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 256 259 252 255 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 247 259 243 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>&#8722;/&#8722;</sup>/Rb<sup>+/+</sup></italic>
###xml 292 295 288 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 298 301 294 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 289 301 285 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53<sup>+/+</sup>/Rb<sup>+/+</sup></italic>
###xml 338 341 334 337 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 336 341 332 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb<sup>&#8722;/&#8722;</sup></italic>
###xml 417 429 413 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 455 464 447 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figures 1</xref>
###xml 470 471 462 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4</xref>
###xml 617 629 609 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 664 672 652 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 676 685 664 673 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4.</label>
###xml 710 722 698 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 758 759 742 743 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 805 817 785 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 992 993 968 969 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1030 1042 1006 1014 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 1383 1391 1349 1357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1394 1395 1360 1361 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1734 1735 1700 1701 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1780 1792 1746 1754 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 2148 2156 2106 2114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 2159 2160 2117 2118 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 2568 2569 2522 2523 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 685 3221 673 3171 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="57">HMGB1 up-regulates human <italic>topo II&#945;</italic> gene promoter in pRb-minus cells. (<bold>A</bold>) The plasmid pTII&#945;-617 bearing the human <italic>topo II&#945;</italic> gene promoter was co-transfected with either vector (empty bars) or plasmid encoding HMGB1 (black bars) into pRb-negative Saos-2 cells or pRb-positive H1299 or MCF-7 cells. (<bold>B</bold>) Up-regulation of activity of human <italic>topo II&#945;</italic> promoter by HMGB1 is inhibited by wild-type but not mutant pRb. Saos-2 cells were transiently transfected with the plasmid pTopoII&#945;-617 and plasmids encoding the wild-type retinoblastoma protein pRb, mutant pRb (amino-acid 706 C&#8594;F) or human HMGB2. Luciferase activity (transactivation) in (A) and (B) was measured and presented as in <xref ref-type="fig" rid="F1">Figure 1</xref>. (<bold>C</bold>) Knock-down of pRb in H1299 cells. Nuclear lysates from untransfected cells (lane 1), cells transfected with control siRNA (lane 2) or Rb specific siRNAs (lane 3) were resolved by SDS-polyacrylamide gel electrophoresis, and the proteins were then transferred onto the membrane and immunodetected using anti-pRb or anti-actin antibodies. (<bold>D</bold>) HMGB1 significantly stimulates activity of <italic>topo II&#945;</italic> gene promoter in H1299 cells upon knock-down of pRb. Control siRNA or Rb specific siRNAs were transiently co-transfected with plasmid pTII&#945;-617 and either empty pcDNA3 vector or plasmid encoding HMGB1 into pRb-positive H1299 cells as detailed in the Material and methods section. Luciferase activity (transactivation) was measured and presented as in <xref ref-type="fig" rid="F1">Figure 1</xref>. (<bold>E</bold>) Interaction of HMGB1 with pRb in H1299 cells. Cellular lysates from pRb-positive Saos-2 cells were immunoprecipitated (IP) with monoclonal &#945;-HMGB1 antibody or control (pre-immune) IgG, followed by separation of the precipitated proteins by SDS-polyacrylamide gel electrophoresis, western blotting and immunodetection with polyclonal anti-pRb antibody as detailed in the Materials and methods section. (<bold>F</bold>) Schematic structures of pRb and pRb constructs (upper panel) used for the &#8216;pull-down&#8217; assay (upper panel). GST or GST-pRb (wild-type or mutant) were immobilized on glutathione Sepharose beads and incubated with purified HMGB1 protein. After extensive washing of the beads, the proteins associated with the beads were resolved electrophoresis, followed by western blotting and immunological detection by &#945;-HMGB1 antibody as detailed in Material and methods section. Equal amounts of GST-pRb immobilized on beads were confirmed by immunodetection using anti-pRb (C-15) antibody (lanes 2 and 3). Input, 10% of the HMGB1 used for the pull-down assay.</p>
###xml 685 3221 673 3171 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="57">HMGB1 up-regulates human <italic>topo II&#945;</italic> gene promoter in pRb-minus cells. (<bold>A</bold>) The plasmid pTII&#945;-617 bearing the human <italic>topo II&#945;</italic> gene promoter was co-transfected with either vector (empty bars) or plasmid encoding HMGB1 (black bars) into pRb-negative Saos-2 cells or pRb-positive H1299 or MCF-7 cells. (<bold>B</bold>) Up-regulation of activity of human <italic>topo II&#945;</italic> promoter by HMGB1 is inhibited by wild-type but not mutant pRb. Saos-2 cells were transiently transfected with the plasmid pTopoII&#945;-617 and plasmids encoding the wild-type retinoblastoma protein pRb, mutant pRb (amino-acid 706 C&#8594;F) or human HMGB2. Luciferase activity (transactivation) in (A) and (B) was measured and presented as in <xref ref-type="fig" rid="F1">Figure 1</xref>. (<bold>C</bold>) Knock-down of pRb in H1299 cells. Nuclear lysates from untransfected cells (lane 1), cells transfected with control siRNA (lane 2) or Rb specific siRNAs (lane 3) were resolved by SDS-polyacrylamide gel electrophoresis, and the proteins were then transferred onto the membrane and immunodetected using anti-pRb or anti-actin antibodies. (<bold>D</bold>) HMGB1 significantly stimulates activity of <italic>topo II&#945;</italic> gene promoter in H1299 cells upon knock-down of pRb. Control siRNA or Rb specific siRNAs were transiently co-transfected with plasmid pTII&#945;-617 and either empty pcDNA3 vector or plasmid encoding HMGB1 into pRb-positive H1299 cells as detailed in the Material and methods section. Luciferase activity (transactivation) was measured and presented as in <xref ref-type="fig" rid="F1">Figure 1</xref>. (<bold>E</bold>) Interaction of HMGB1 with pRb in H1299 cells. Cellular lysates from pRb-positive Saos-2 cells were immunoprecipitated (IP) with monoclonal &#945;-HMGB1 antibody or control (pre-immune) IgG, followed by separation of the precipitated proteins by SDS-polyacrylamide gel electrophoresis, western blotting and immunodetection with polyclonal anti-pRb antibody as detailed in the Materials and methods section. (<bold>F</bold>) Schematic structures of pRb and pRb constructs (upper panel) used for the &#8216;pull-down&#8217; assay (upper panel). GST or GST-pRb (wild-type or mutant) were immobilized on glutathione Sepharose beads and incubated with purified HMGB1 protein. After extensive washing of the beads, the proteins associated with the beads were resolved electrophoresis, followed by western blotting and immunological detection by &#945;-HMGB1 antibody as detailed in Material and methods section. Equal amounts of GST-pRb immobilized on beads were confirmed by immunodetection using anti-pRb (C-15) antibody (lanes 2 and 3). Input, 10% of the HMGB1 used for the pull-down assay.</p></caption>
###xml 3221 3221 3171 3171 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkp067f4"/>
###xml 676 3221 664 3171 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F4" position="float"><label>Figure 4.</label><caption><p textid="57">HMGB1 up-regulates human <italic>topo II&#945;</italic> gene promoter in pRb-minus cells. (<bold>A</bold>) The plasmid pTII&#945;-617 bearing the human <italic>topo II&#945;</italic> gene promoter was co-transfected with either vector (empty bars) or plasmid encoding HMGB1 (black bars) into pRb-negative Saos-2 cells or pRb-positive H1299 or MCF-7 cells. (<bold>B</bold>) Up-regulation of activity of human <italic>topo II&#945;</italic> promoter by HMGB1 is inhibited by wild-type but not mutant pRb. Saos-2 cells were transiently transfected with the plasmid pTopoII&#945;-617 and plasmids encoding the wild-type retinoblastoma protein pRb, mutant pRb (amino-acid 706 C&#8594;F) or human HMGB2. Luciferase activity (transactivation) in (A) and (B) was measured and presented as in <xref ref-type="fig" rid="F1">Figure 1</xref>. (<bold>C</bold>) Knock-down of pRb in H1299 cells. Nuclear lysates from untransfected cells (lane 1), cells transfected with control siRNA (lane 2) or Rb specific siRNAs (lane 3) were resolved by SDS-polyacrylamide gel electrophoresis, and the proteins were then transferred onto the membrane and immunodetected using anti-pRb or anti-actin antibodies. (<bold>D</bold>) HMGB1 significantly stimulates activity of <italic>topo II&#945;</italic> gene promoter in H1299 cells upon knock-down of pRb. Control siRNA or Rb specific siRNAs were transiently co-transfected with plasmid pTII&#945;-617 and either empty pcDNA3 vector or plasmid encoding HMGB1 into pRb-positive H1299 cells as detailed in the Material and methods section. Luciferase activity (transactivation) was measured and presented as in <xref ref-type="fig" rid="F1">Figure 1</xref>. (<bold>E</bold>) Interaction of HMGB1 with pRb in H1299 cells. Cellular lysates from pRb-positive Saos-2 cells were immunoprecipitated (IP) with monoclonal &#945;-HMGB1 antibody or control (pre-immune) IgG, followed by separation of the precipitated proteins by SDS-polyacrylamide gel electrophoresis, western blotting and immunodetection with polyclonal anti-pRb antibody as detailed in the Materials and methods section. (<bold>F</bold>) Schematic structures of pRb and pRb constructs (upper panel) used for the &#8216;pull-down&#8217; assay (upper panel). GST or GST-pRb (wild-type or mutant) were immobilized on glutathione Sepharose beads and incubated with purified HMGB1 protein. After extensive washing of the beads, the proteins associated with the beads were resolved electrophoresis, followed by western blotting and immunological detection by &#945;-HMGB1 antibody as detailed in Material and methods section. Equal amounts of GST-pRb immobilized on beads were confirmed by immunodetection using anti-pRb (C-15) antibody (lanes 2 and 3). Input, 10% of the HMGB1 used for the pull-down assay.</p></caption><graphic xlink:href="gkp067f4"/></fig>
###xml 61 66 <span type="species:ncbi:9606">human</span>
###xml 262 267 <span type="species:ncbi:9606">human</span>
###xml 306 311 <span type="species:ncbi:9606">human</span>
###xml 606 611 <span type="species:ncbi:9606">human</span>
###xml 704 709 <span type="species:ncbi:9606">human</span>
###xml 799 804 <span type="species:ncbi:9606">human</span>
###xml 1024 1029 <span type="species:ncbi:9606">human</span>
###xml 1284 1289 <span type="species:ncbi:9606">human</span>
In order to find out whether HMGB1 modulates activity of the human topo IIalpha gene promoter in other cell lines than the Saos-2 (p53-/-/Rb-/-) cells, comparative transfection experiments were performed with non-small lung cells carcinoma H1299 (p53-/-/Rb+/+), human breast cancer MCF-7 (p53+/+/Rb+/+) or human bladder carcinoma 5637 (Rb-/-) cells. While over-expression of HMGB1 could significantly up-regulate the topo IIalpha promoter both in Saos-2 (Figures 1A and 4A) and 5637 cells (data not shown), over-expression of HMGB1 had a relatively little (<2-3-fold) effect on the activity of the -617 bp human gene topo IIalpha promoter in MCF-7 or H1299 cells (Figure 4A). Figure 4.HMGB1 up-regulates human topo IIalpha gene promoter in pRb-minus cells. (A) The plasmid pTIIalpha-617 bearing the human topo IIalpha gene promoter was co-transfected with either vector (empty bars) or plasmid encoding HMGB1 (black bars) into pRb-negative Saos-2 cells or pRb-positive H1299 or MCF-7 cells. (B) Up-regulation of activity of human topo IIalpha promoter by HMGB1 is inhibited by wild-type but not mutant pRb. Saos-2 cells were transiently transfected with the plasmid pTopoIIalpha-617 and plasmids encoding the wild-type retinoblastoma protein pRb, mutant pRb (amino-acid 706 C-->F) or human HMGB2. Luciferase activity (transactivation) in (A) and (B) was measured and presented as in Figure 1. (C) Knock-down of pRb in H1299 cells. Nuclear lysates from untransfected cells (lane 1), cells transfected with control siRNA (lane 2) or Rb specific siRNAs (lane 3) were resolved by SDS-polyacrylamide gel electrophoresis, and the proteins were then transferred onto the membrane and immunodetected using anti-pRb or anti-actin antibodies. (D) HMGB1 significantly stimulates activity of topo IIalpha gene promoter in H1299 cells upon knock-down of pRb. Control siRNA or Rb specific siRNAs were transiently co-transfected with plasmid pTIIalpha-617 and either empty pcDNA3 vector or plasmid encoding HMGB1 into pRb-positive H1299 cells as detailed in the Material and methods section. Luciferase activity (transactivation) was measured and presented as in Figure 1. (E) Interaction of HMGB1 with pRb in H1299 cells. Cellular lysates from pRb-positive Saos-2 cells were immunoprecipitated (IP) with monoclonal alpha-HMGB1 antibody or control (pre-immune) IgG, followed by separation of the precipitated proteins by SDS-polyacrylamide gel electrophoresis, western blotting and immunodetection with polyclonal anti-pRb antibody as detailed in the Materials and methods section. (F) Schematic structures of pRb and pRb constructs (upper panel) used for the 'pull-down' assay (upper panel). GST or GST-pRb (wild-type or mutant) were immobilized on glutathione Sepharose beads and incubated with purified HMGB1 protein. After extensive washing of the beads, the proteins associated with the beads were resolved electrophoresis, followed by western blotting and immunological detection by alpha-HMGB1 antibody as detailed in Material and methods section. Equal amounts of GST-pRb immobilized on beads were confirmed by immunodetection using anti-pRb (C-15) antibody (lanes 2 and 3). Input, 10% of the HMGB1 used for the pull-down assay.
###end p 56
###begin p 57
###xml 25 37 25 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 73 74 69 70 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 120 132 112 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 307 308 295 296 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 345 357 333 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 698 706 676 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 709 710 687 688 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1049 1050 1027 1028 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1095 1107 1073 1081 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 1463 1471 1433 1441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1474 1475 1444 1445 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 1883 1884 1849 1850 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 19 24 <span type="species:ncbi:9606">human</span>
###xml 114 119 <span type="species:ncbi:9606">human</span>
###xml 339 344 <span type="species:ncbi:9606">human</span>
###xml 599 604 <span type="species:ncbi:9606">human</span>
HMGB1 up-regulates human topo IIalpha gene promoter in pRb-minus cells. (A) The plasmid pTIIalpha-617 bearing the human topo IIalpha gene promoter was co-transfected with either vector (empty bars) or plasmid encoding HMGB1 (black bars) into pRb-negative Saos-2 cells or pRb-positive H1299 or MCF-7 cells. (B) Up-regulation of activity of human topo IIalpha promoter by HMGB1 is inhibited by wild-type but not mutant pRb. Saos-2 cells were transiently transfected with the plasmid pTopoIIalpha-617 and plasmids encoding the wild-type retinoblastoma protein pRb, mutant pRb (amino-acid 706 C-->F) or human HMGB2. Luciferase activity (transactivation) in (A) and (B) was measured and presented as in Figure 1. (C) Knock-down of pRb in H1299 cells. Nuclear lysates from untransfected cells (lane 1), cells transfected with control siRNA (lane 2) or Rb specific siRNAs (lane 3) were resolved by SDS-polyacrylamide gel electrophoresis, and the proteins were then transferred onto the membrane and immunodetected using anti-pRb or anti-actin antibodies. (D) HMGB1 significantly stimulates activity of topo IIalpha gene promoter in H1299 cells upon knock-down of pRb. Control siRNA or Rb specific siRNAs were transiently co-transfected with plasmid pTIIalpha-617 and either empty pcDNA3 vector or plasmid encoding HMGB1 into pRb-positive H1299 cells as detailed in the Material and methods section. Luciferase activity (transactivation) was measured and presented as in Figure 1. (E) Interaction of HMGB1 with pRb in H1299 cells. Cellular lysates from pRb-positive Saos-2 cells were immunoprecipitated (IP) with monoclonal alpha-HMGB1 antibody or control (pre-immune) IgG, followed by separation of the precipitated proteins by SDS-polyacrylamide gel electrophoresis, western blotting and immunodetection with polyclonal anti-pRb antibody as detailed in the Materials and methods section. (F) Schematic structures of pRb and pRb constructs (upper panel) used for the 'pull-down' assay (upper panel). GST or GST-pRb (wild-type or mutant) were immobilized on glutathione Sepharose beads and incubated with purified HMGB1 protein. After extensive washing of the beads, the proteins associated with the beads were resolved electrophoresis, followed by western blotting and immunological detection by alpha-HMGB1 antibody as detailed in Material and methods section. Equal amounts of GST-pRb immobilized on beads were confirmed by immunodetection using anti-pRb (C-15) antibody (lanes 2 and 3). Input, 10% of the HMGB1 used for the pull-down assay.
###end p 57
###begin p 58
###xml 98 110 98 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 322 324 318 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 489 491 481 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
The above results led us to hypothesize that the distinct effects of HMGB1 on the activity of the topo IIalpha promoter in different cell lines could be explained by the presence of retinoblastoma susceptibility protein pRb. pRb is a negative regulator of cellular proliferation and a prototypic tumor suppressor protein (40). pRb is also required for efficient activation of cell cycle checkpoints in response to a variety of DNA lesions, including those induced by topo IIalpha poisons (41).
###end p 58
###begin p 59
###xml 91 103 91 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 462 481 458 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pRb over-expression</italic>
###xml 583 591 579 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 614 626 610 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 885 897 865 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 921 929 897 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1068 1070 1044 1046 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 1261 1273 1237 1245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 1289 1306 1261 1278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Knock-down of pRb</italic>
###xml 1371 1379 1343 1351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1458 1470 1418 1426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 1517 1525 1473 1481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1627 1639 1583 1591 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 1683 1685 1635 1637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 1885 1893 1825 1833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 2046 2058 1986 1994 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 2198 2206 2122 2130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 2283 2295 2207 2215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
To find out whether the absence of functional pRb could explain why HMGB1 up-regulated the topo IIalpha promoter much more efficiently in pRb-negative as compared to pRb-positive cells, the impact of HMGB1 over-expression on the activity of the promoter was studied in the luciferase gene reporter assays using two different approaches: pRb was (i) over-expressed in pRb-negative Saos-2 cells or (ii) silenced by specific siRNAs in pRb-positive H1299 cells. (i) pRb over-expression. pRb was ectopically expressed in Saos-2 cells and the luciferase activity was measured. As shown in Figure 4B, the activity of the topo IIalpha promoter was significantly inhibited (up to approximately3-4-fold) when pRb alone was over-expressed in Saos-2 cells. When HMGB1 (plasmid-encoded) was over-expressed in the Saos-2 cells transiently expressing pRb, very little, if any, transactivation of the topo IIalpha promoter was observed (Figure 4B). Similar results were obtained when HMGB1 was transiently over-expressed in stable Saos-2 cell derivatives in which the activity of the Rb gene was controlled by the tetracycline regulated promoter (data not shown). These results indicated that ectopically-expressed pRb could counteract the stimulatory effect of HMGB1 over the topo IIalpha promoter. (ii) Knock-down of pRb. Silencing of pRb expression in H1299 cells by specific siRNAs (Figure 4C) could significantly enhance (up to approximately3-fold) the activity of the topo IIalpha promoter in a luciferase gene reporter assay (Figure 4D), in agreement with previously published microarray study demonstrating an enhanced activity of the topo IIalpha gene upon silencing of pRb in H1299 cells (44). Co-transfection of the cells with silenced expression of pRb with plasmid encoding HMGB1 could increase the activity of the promoter in a luciferase gene reporter assay up to approximately12-fold (Figure 4D). This was in contrast to the gene reporter assay using either no siRNA or control siRNA. While the control siRNA had no effect on the activity of the topo IIalpha promoter, co-transfection of these cells with plasmid encoding HMGB1 could increase the activity of the promoter only approximately2-fold (Figure 4D). The above results provided strong evidence that the up-regulation of the topo IIalpha promoter by HMGB1 was inhibited by pRb.
###end p 59
###begin p 60
###xml 252 254 252 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 417 425 417 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 562 564 562 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 749 761 747 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 784 792 778 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 831 843 825 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 1087 1099 1077 1085 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 1126 1134 1112 1120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 48 53 <span type="species:ncbi:9606">human</span>
###xml 472 477 <span type="species:ncbi:9606">human</span>
pRb protein is functionally inactivated in most human neoplasms either by direct mutation/deletion (such as occurs in osteosarcoma, retinoblastoma and small cell lung carcinoma) or indirectly through altered expression/activity of upstream regulators (42). pRb is a 928 amino-acid protein with functionally distinct protein-binding domains. The A/B pocket (residues 379-792), comprised of structural domains A and B (Figure 4F, upper panel), is a hot-spot for mutation in human cancers, and is the binding site of several viral oncoproteins that inactivate pRb (42). We have therefore tested whether mutation of pRb within the A/B pocket (amino-acid 706 C --> F) could abolish the inhibitory effect of pRb on the HMGB1-mediated up-regulation of the topo IIalpha promoter. As shown in Figure 4B, the transcriptional activity of the topo IIalpha promoter in Saos-2 cells (in the absence of over-expressed HMGB1) was very little (if any) affected by transient expression of the mutant pRb. Similarly, the mutant pRb could not inhibit the HMGB1-mediated up-regulation of the activity of the topo IIalpha promoter in Saos-2 cells (Figure 4B).
###end p 60
###begin p 61
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 462 474 462 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 626 628 622 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 815 823 811 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 953 960 949 956 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1191 1199 1187 1195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1329 1337 1325 1333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1350 1352 1346 1348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 456 461 <span type="species:ncbi:9606">human</span>
###xml 1081 1086 <span type="species:ncbi:9606">human</span>
###xml 1179 1185 <span type="species:ncbi:9986">rabbit</span>
A large number of proteins have been demonstrated to interact with pRb, the majority of which are involved in transcriptional repression such as histone deacetylases, components of the mammalian SWI/SNF chromatin-remodeling complex, histone methyltransferases, heterochromatin proteins, DNA methyltransferases and Polycomb group proteins (42). Therefore, we have used PD assay to study whether pRb could interact with factors affecting the activity of the human topo IIalpha promoter, HMGB1 or NF-Y. Previous PD experiments revealed that HMGB1 and recombinant pRb (unphosphorylated form) physically interact in free solution (28). In order to clarify whether HMGB1 could interact with pRb in the cell, nuclear lysate from pRb-positive H1299 cells was immunoprecipitated by specific anti-HMGB1 antibody. As shown in Figure 4E, a weak band of co-immunoprecipitated pRb from H1299 lysate with HMGB1 was apparent, suggesting an interaction of HMGB1 and pRb in vivo (co-immunoprecipitation of pRb with HMGB1 was also evident by immunoprecipitation experiments using nuclear lysate from human erythroleukemia K562 cells, unpublished). pRb was not co-immunoprecipitated with pre-immune rabbit IgG (Figure 4E). The electrophoretic mobility of the co-immunoprecipitated pRb corresponded to the non-phosphorylated form of the pRb protein [Figure 4E, see also (43)], although we have not yet determined directly the phosphorylation state of pRb involved in the interaction with HMGB1.
###end p 61
###begin p 62
###xml 136 148 136 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 159 167 155 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 412 420 406 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 687 695 669 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 758 770 740 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 819 827 797 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 927 935 905 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
To find out whether the different effect of the wild-type and mutant pRb on the inhibition of the HMGB1-mediated transactivation of the topo IIalpha promoter (Figure 4B) could be explained by the different interaction of HMGB1 with the wild-type pRb and mutant pRb, the PD assay was performed. Although HMGB1 could bind to both the wild-type and mutant pRb (amino-acid 706 C --> Y within the A/B pocket domain) (Figure 4F), a higher fraction of HMGB1 (approximately2-3-fold) was associated with the wild-type pRb than with the mutant pRb (equal amounts of GST-pRb immobilized on the glutathione-Sepharose beads were confirmed by immunodetection using anti-pRb antibody; lanes 1 and 2 in Figure 4E). Thus, the distinct effects of HMGB1 on the activity of the topo IIalpha promoter in pRb-negative or pRb-positive cells (Figure 4A) could not be explained solely by different affinities of the wild-type and mutant pRb for HMGB1 (Figure 4F).
###end p 62
###begin p 63
###xml 93 105 93 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 167 175 163 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 189 197 185 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 691 699 687 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 718 726 714 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 1108 1116 1104 1112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 1215 1223 1211 1219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 1466 1475 1462 1471 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5.</label>
###xml 1476 1477 1472 1473 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1975 1976 1966 1967 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 2001 2012 1992 2000 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#946;</italic>
###xml 2092 2103 2080 2088 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#946;</italic>
###xml 2321 2329 2306 2314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1475 2330 1471 2315 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="64">(<bold>A</bold>) pRb can reduce NF-Y binding to ICEs. Radioactively labeled 30-bp DNA duplex containing the ICE2 was mixed with nuclear extract from Saos-2 cells (lane 1) or nuclear extract containing increasing amounts of recombinant His-pRb [lane 2 (0.1 &#956;g), lanes 3 and 7 (0.2 &#956;g), lanes 4 and 8 (0.4 &#956;g)]. In some reactions, HMGB1 was added [lane 5 (1 &#956;M), lanes 6-8 (4 &#956;M)]. Unbound DNA duplexes (free probe) and the DNA&#8211;protein complexes were resolved on 5% non-denaturing polyacrylamide gels (EMSA). (<bold>B</bold>) Up-regulation of human <italic>topo II&#946;</italic> gene promoter by HMGB1 and HMGB2. The plasmid -700TOP2B-pGL3 bearing the human <italic>topo II&#946;</italic> gene promoter was co-transfected with either pGL3 vector (empty bars), plasmid encoding HMGB1 (black bars) or plasmid encoding HMGB2 (gray bars) into the Saos-2 cells. Luciferase activity is presented as indicated in <xref ref-type="fig" rid="F1">Figure 1</xref>.</p>
###xml 1475 2330 1471 2315 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="64">(<bold>A</bold>) pRb can reduce NF-Y binding to ICEs. Radioactively labeled 30-bp DNA duplex containing the ICE2 was mixed with nuclear extract from Saos-2 cells (lane 1) or nuclear extract containing increasing amounts of recombinant His-pRb [lane 2 (0.1 &#956;g), lanes 3 and 7 (0.2 &#956;g), lanes 4 and 8 (0.4 &#956;g)]. In some reactions, HMGB1 was added [lane 5 (1 &#956;M), lanes 6-8 (4 &#956;M)]. Unbound DNA duplexes (free probe) and the DNA&#8211;protein complexes were resolved on 5% non-denaturing polyacrylamide gels (EMSA). (<bold>B</bold>) Up-regulation of human <italic>topo II&#946;</italic> gene promoter by HMGB1 and HMGB2. The plasmid -700TOP2B-pGL3 bearing the human <italic>topo II&#946;</italic> gene promoter was co-transfected with either pGL3 vector (empty bars), plasmid encoding HMGB1 (black bars) or plasmid encoding HMGB2 (gray bars) into the Saos-2 cells. Luciferase activity is presented as indicated in <xref ref-type="fig" rid="F1">Figure 1</xref>.</p></caption>
###xml 2330 2330 2315 2315 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkp067f5"/>
###xml 1466 2330 1462 2315 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F5" position="float"><label>Figure 5.</label><caption><p textid="64">(<bold>A</bold>) pRb can reduce NF-Y binding to ICEs. Radioactively labeled 30-bp DNA duplex containing the ICE2 was mixed with nuclear extract from Saos-2 cells (lane 1) or nuclear extract containing increasing amounts of recombinant His-pRb [lane 2 (0.1 &#956;g), lanes 3 and 7 (0.2 &#956;g), lanes 4 and 8 (0.4 &#956;g)]. In some reactions, HMGB1 was added [lane 5 (1 &#956;M), lanes 6-8 (4 &#956;M)]. Unbound DNA duplexes (free probe) and the DNA&#8211;protein complexes were resolved on 5% non-denaturing polyacrylamide gels (EMSA). (<bold>B</bold>) Up-regulation of human <italic>topo II&#946;</italic> gene promoter by HMGB1 and HMGB2. The plasmid -700TOP2B-pGL3 bearing the human <italic>topo II&#946;</italic> gene promoter was co-transfected with either pGL3 vector (empty bars), plasmid encoding HMGB1 (black bars) or plasmid encoding HMGB2 (gray bars) into the Saos-2 cells. Luciferase activity is presented as indicated in <xref ref-type="fig" rid="F1">Figure 1</xref>.</p></caption><graphic xlink:href="gkp067f5"/></fig>
###xml 87 92 <span type="species:ncbi:9606">human</span>
###xml 1995 2000 <span type="species:ncbi:9606">human</span>
###xml 2086 2091 <span type="species:ncbi:9606">human</span>
In order to understand the mechanism of pRb-mediated inhibition of the activity of the human topo IIalpha promoter, we have asked whether pRb could interact with NF-Y in vitro. As shown in Figure 2D (top), incubation of nuclear lysate from Saos-2 cells with GST-pRb immobilized on glutathione-agarose beads resulted in association of NF-Y with pRb. Similarly to the NF-Y binding to HMGB1, the interaction between NF-Y and pRb was not facilitated via DNA as similar results were obtained by PD assays in the presence or absence of ethidium bromide. The detection of pRb-(NF-Y) interactions prompted us to investigate using EMSA whether pRb could affect NF-Y binding to the specific ICE sites in vitro. Results shown in Figure 5A (lanes 2-5) demonstrated that binding of NF-Y to a short DNA duplex containing the ICE2 was visibly compromised by preincubation of nuclear lysate from Saos-2 cells with pRb (similar results were obtained from EMSA experiments using the ICE1, not shown). In addition, the HMGB1-mediated enhancement of NF-Y binding to the ICE2 was also reduced by preincubation of HMGB1 with pRb (Figure 5A; compare lanes 6, 7 and 8). We have verified that the observed reduction of NF-Y binding by pRb (Figure 5A) was not unspecific, as titration with un unrelated protein (GST) in comparable amounts to pRb had no effect (not shown). The above results suggested that pRb could counteract NF-Y binding to DNA duplexes containing inverted CCAAT elements. Figure 5.(A) pRb can reduce NF-Y binding to ICEs. Radioactively labeled 30-bp DNA duplex containing the ICE2 was mixed with nuclear extract from Saos-2 cells (lane 1) or nuclear extract containing increasing amounts of recombinant His-pRb [lane 2 (0.1 mug), lanes 3 and 7 (0.2 mug), lanes 4 and 8 (0.4 mug)]. In some reactions, HMGB1 was added [lane 5 (1 muM), lanes 6-8 (4 muM)]. Unbound DNA duplexes (free probe) and the DNA-protein complexes were resolved on 5% non-denaturing polyacrylamide gels (EMSA). (B) Up-regulation of human topo IIbeta gene promoter by HMGB1 and HMGB2. The plasmid -700TOP2B-pGL3 bearing the human topo IIbeta gene promoter was co-transfected with either pGL3 vector (empty bars), plasmid encoding HMGB1 (black bars) or plasmid encoding HMGB2 (gray bars) into the Saos-2 cells. Luciferase activity is presented as indicated in Figure 1.
###end p 63
###begin p 64
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 500 501 495 496 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 526 537 521 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#946;</italic>
###xml 617 628 609 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#946;</italic>
###xml 846 854 835 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 520 525 <span type="species:ncbi:9606">human</span>
###xml 611 616 <span type="species:ncbi:9606">human</span>
(A) pRb can reduce NF-Y binding to ICEs. Radioactively labeled 30-bp DNA duplex containing the ICE2 was mixed with nuclear extract from Saos-2 cells (lane 1) or nuclear extract containing increasing amounts of recombinant His-pRb [lane 2 (0.1 mug), lanes 3 and 7 (0.2 mug), lanes 4 and 8 (0.4 mug)]. In some reactions, HMGB1 was added [lane 5 (1 muM), lanes 6-8 (4 muM)]. Unbound DNA duplexes (free probe) and the DNA-protein complexes were resolved on 5% non-denaturing polyacrylamide gels (EMSA). (B) Up-regulation of human topo IIbeta gene promoter by HMGB1 and HMGB2. The plasmid -700TOP2B-pGL3 bearing the human topo IIbeta gene promoter was co-transfected with either pGL3 vector (empty bars), plasmid encoding HMGB1 (black bars) or plasmid encoding HMGB2 (gray bars) into the Saos-2 cells. Luciferase activity is presented as indicated in Figure 1.
###end p 64
###begin p 65
###xml 200 201 188 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 416 417 404 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 418 419 406 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 564 576 552 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 604 612 588 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 724 736 696 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 1045 1057 1013 1021 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 469 474 <span type="species:ncbi:9606">human</span>
HMGB-type family consists of three member-HMGB1, HMGB2 and HMGB3 with an 80% amino-acid identity among the three proteins. While HMGB1 is ubiquitously expressed in all mammalian cells (approximately106 molecules per cell), expression of the other two family members is more restricted: HMGB2 is widely expressed during embryonic development, and HMGB3 is only expressed to a significant amount during embryogenesis (5,8). As both HMGB1 and HMGB2 relatively abundant in human cells (including Saos-2 cells), we have studied whether HMGB2 could also up-regulate the topo IIalpha gene promoter. As shown in Figure 4B, over-expression of HMGB2 in Saos-2 cells resulted in up to approximately2-fold higher transactivation of the topo IIalpha gene promoter relative to the effect of HMGB1. The latter was not due to different over-expression of HMGB1 and HMGB2 as similar levels of the two ectopically expressed proteins were immunodetected in transfected Saos-2 cells (not shown). Thus, it is likely that both HMGB1 and HMGB2 could transactivate the topo IIalpha gene in the cell.
###end p 65
###begin p 66
###xml 151 154 144 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1 B2 B3 B4">1&#8211;4</xref>
###xml 189 201 182 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 322 333 311 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#946;</italic>
###xml 393 395 379 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B49">49</xref>
###xml 439 446 425 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II</italic>
###xml 463 465 449 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B49">49</xref>
###xml 521 523 507 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B49">49</xref>
###xml 651 662 637 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#946;</italic>
###xml 685 693 668 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 716 727 699 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#946;</italic>
###xml 814 826 794 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 837 845 813 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 876 887 852 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#946;</italic>
###xml 947 955 920 928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 990 1002 963 971 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 1007 1018 976 984 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#946;</italic>
###xml 183 188 <span type="species:ncbi:9606">human</span>
###xml 316 321 <span type="species:ncbi:9606">human</span>
The two isoforms of topoisomerase II, alpha and beta, exhibit very similar catalytic activities, but differ in their production during the cell cycle (1-4). While the activity of the human topo IIalpha gene promoter was low in resting cells and enhanced during proliferation (such as in tumors), the activity of the human topo IIbeta gene promoter remained constant throughout the cell cycle (49). Despite a distinct regulation of the two topo II gene promoters (49), NF-Y could bind to ICEs of both types of promoters [(49) and refs therein]. Therefore we were wondering whether HMGB1 and/or HMGB2 could also modulate transcriptional activity of the topo IIbeta promoter. As shown in Figure 5B, the activity of the topo IIbeta promoter in Saos-2 cells was dose-dependently up-regulated by HMGB1. Similarly to the topo IIalpha promoter (Figure 4B), the transactivation of the topo IIbeta promoter was more prominent upon over-expression of HMGB2 (Figure 5B). Thus, the activity of both the topo IIalpha and topo IIbeta promoters could be up-regulated by HMGB1/2.
###end p 66
###begin title 67
HMGB1 and HMGB2 modulate cellular expression of topoisomerase IIalpha
###end title 67
###begin p 68
###xml 73 85 73 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 134 143 130 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figures 1</xref>
###xml 148 149 144 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4</xref>
###xml 473 478 461 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HMGB1</italic>
###xml 482 487 470 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HMGB1</italic>
###xml 488 493 476 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HMGB2</italic>
###xml 736 744 724 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 830 835 818 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HMGB1</italic>
###xml 864 869 852 857 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HMGB1</italic>
###xml 874 879 862 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HMGB2</italic>
###xml 1105 1113 1081 1089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 1305 1313 1281 1289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 1372 1381 1348 1357 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6.</label>
###xml 1381 1883 1357 1855 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="69">Knock-down of HMGB1 and HMGB2 results in inhibition of topo II&#945; expression. Nuclear lysates from untransfected (lanes 1) and mock-transfected (lanes 2) cells, as well as from cells transfected with plasmids producing shRNAs specific for HMGB1 (lanes 3, construct #A) or HMGB1/HMGB2 (lanes 4, construct #B) were resolved on SDS-polyacrylamide gels and transferred onto the membranes by western blotting. Proteins were detected by specific antibodies as detailed in the Materials and methods section.</p>
###xml 1381 1883 1357 1855 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="69">Knock-down of HMGB1 and HMGB2 results in inhibition of topo II&#945; expression. Nuclear lysates from untransfected (lanes 1) and mock-transfected (lanes 2) cells, as well as from cells transfected with plasmids producing shRNAs specific for HMGB1 (lanes 3, construct #A) or HMGB1/HMGB2 (lanes 4, construct #B) were resolved on SDS-polyacrylamide gels and transferred onto the membranes by western blotting. Proteins were detected by specific antibodies as detailed in the Materials and methods section.</p></caption>
###xml 1883 1883 1855 1855 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkp067f6"/>
###xml 1372 1883 1348 1855 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F6" position="float"><label>Figure 6.</label><caption><p textid="69">Knock-down of HMGB1 and HMGB2 results in inhibition of topo II&#945; expression. Nuclear lysates from untransfected (lanes 1) and mock-transfected (lanes 2) cells, as well as from cells transfected with plasmids producing shRNAs specific for HMGB1 (lanes 3, construct #A) or HMGB1/HMGB2 (lanes 4, construct #B) were resolved on SDS-polyacrylamide gels and transferred onto the membranes by western blotting. Proteins were detected by specific antibodies as detailed in the Materials and methods section.</p></caption><graphic xlink:href="gkp067f6"/></fig>
Results of this article indicated that HMGB1 and 2 could up-regulate the topo IIalpha promoter in the luciferase gene reporter assay (Figures 1 and 4), suggesting a possibility that HMGB1 and HMGB2 could affect cellular expression of topo IIalpha. To find out whether the cellular levels of topo IIalpha were affected by HMGB1 and/or HMGB2 in Saos-2 or H1299 cells, stable cell lines were generated producing plasmid-encoded short hairpin RNAs (shRNAs) specific for either HMGB1 or HMGB1/HMGB2 mRNAs. In order to verify silencing of HMGB1 and/or HMGB2 expression, proteins from nuclear lysates were resolved by electrophoresis, transferred onto the membrane and detected with specific antibodies recognizing HMGB1 or HMGB2. As shown in Figure 6, the expression of HMGB1 was inhibited in H1299 cells by >90% by shRNAs specific for HMGB1 mRNA (lane 3; H1299) or for HMGB1 and HMGB2 mRNAs (lane 4; H1299). The latter approach resulted in simultaneous knock-down of HMGB1 and HMGB2 expression. Similar results were obtained in Saos-2 cells although silencing of HMGB1 expression was only approximately60-70% (Figure 6, lane 3; Saos-2). Control silencing experiments revealed that the levels of HMGB1 and HMGB2 were unaffected in both H1299 and Saos-2 cells transfected with plasmid producing unrelated shRNA (Figure 6, lanes 2 as compared to lanes 1 for untransfected cells). Figure 6.Knock-down of HMGB1 and HMGB2 results in inhibition of topo IIalpha expression. Nuclear lysates from untransfected (lanes 1) and mock-transfected (lanes 2) cells, as well as from cells transfected with plasmids producing shRNAs specific for HMGB1 (lanes 3, construct #A) or HMGB1/HMGB2 (lanes 4, construct #B) were resolved on SDS-polyacrylamide gels and transferred onto the membranes by western blotting. Proteins were detected by specific antibodies as detailed in the Materials and methods section.
###end p 68
###begin p 69
Knock-down of HMGB1 and HMGB2 results in inhibition of topo IIalpha expression. Nuclear lysates from untransfected (lanes 1) and mock-transfected (lanes 2) cells, as well as from cells transfected with plasmids producing shRNAs specific for HMGB1 (lanes 3, construct #A) or HMGB1/HMGB2 (lanes 4, construct #B) were resolved on SDS-polyacrylamide gels and transferred onto the membranes by western blotting. Proteins were detected by specific antibodies as detailed in the Materials and methods section.
###end p 69
###begin p 70
###xml 292 300 284 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 376 388 368 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 647 655 619 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 768 780 728 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 1010 1018 962 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
The cellular levels of topo IIalpha in cells with silenced HMGB1 or HMGB1/2 expression were then determined by western blotting and immunodetection. No significant changes in topo IIalpha protein levels were observed in pRb-positive H1299 cells upon silencing of HMGB1 or HMGB1/2 expression (Figure 6, lanes 3 and 4; H1299), albeit QRT-PCR analysis revealed minor decrease in topo IIalpha mRNA levels in H1299 cells with silenced HMGB1/2 expression (not shown). On the other hand, the topo IIalpha protein levels in pRb-negative Saos-2 cells with silenced HMGB1/HMGB2 expression were decreased up to approximately3-fold relative to control cells (Figure 6, lane 4; Saos-2). This finding was also supported by QRT-PCR analysis revealing approximately3-fold decrease in topo IIalpha mRNA levels in Saos-2 cells with silenced HMGB1/2 expression (data not shown). The fact that only very little (<20%) decrease in topo IIalpha protein levels was observed when solely HMGB1 expression was silenced in Saos-2 cells (Figure 6, lane 3; Saos-2) may be related to possible functional redundancy of these two closely related HMGB-type proteins (see Discussion section).
###end p 70
###begin p 71
###xml 233 245 229 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 360 362 352 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 412 414 404 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 462 464 454 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 447 452 <span type="species:ncbi:9606">human</span>
In conclusion, we have found that chromosomal proteins HMGB1 and HMGB2 could modulate cellular expression of topo IIalpha in cells lacking functional retinoblastoma gene susceptibility protein pRb by promoting binding of NF-Y to the topo IIalpha gene promoter. Our findings are discussed in the view of reported over-expression of HMGB1/2 proteins in tumors [(17) and refs therein], as well as the fact that the Rb gene is deleted/mutated in >50% human cancers (42).
###end p 71
###begin title 72
DISCUSSION
###end title 72
###begin p 73
###xml 178 180 174 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 289 301 285 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 470 482 462 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 534 536 522 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 97 102 <span type="species:ncbi:9606">human</span>
###xml 283 288 <span type="species:ncbi:9606">human</span>
Recently we have reported that chromosomal protein HMGB1 could stimulate catalytic activities of human topoisomerase IIalpha by enhancing DNA binding and cleavage by the enzyme (11). Here we report that HMGB1 and its close relative, HMGB2, could also up-regulate the activity of the human topo IIalpha gene promoter and cellular expression of the enzyme. Our results suggest that HMGB1 and HMGB2 proteins may serve as positive regulators of the cellular activity of the topo IIalpha gene (this article) as well as that of the enzyme (11).
###end p 73
###begin p 74
###xml 173 174 173 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 175 176 175 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 373 375 373 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 376 378 376 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47">47</xref>
###xml 446 447 446 447 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</underline>
###xml 588 596 588 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 663 664 663 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 665 666 665 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 667 668 667 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 816 818 816 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48">48</xref>
###xml 1311 1317 1307 1313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hHMGB2</italic>
###xml 209 213 <span type="species:ncbi:10090">mice</span>
###xml 356 360 <span type="species:ncbi:10090">mice</span>
###xml 419 423 <span type="species:ncbi:10090">mice</span>
###xml 671 677 <span type="species:ncbi:10090">Murine</span>
###xml 682 687 <span type="species:ncbi:9606">human</span>
HMGB1 and HMGB2 proteins have been implicated in regulation of chromatin structure and DNA metabolic processes such as transcription, replication, recombination and repair (5,8). The lack of HMGB1 in knockout mice results in death within a few hours after birth due to inefficient activation of glucocorticoid receptor responsive genes, but HMGB2 knockout mice are viable (15,47). HMGB2 protein could not substitute in mice for the loss of HMGB1 (15,47), suggesting that HMGB1 and HMGB2 proteins may have distinct roles, albeit most of the reported DNA-binding studies indicated that the in vitro DNA-binding properties of HMGB1 and HMGB2 were indistinguishable (5,7,8). Murine and human cells were viable without functional HMGB1, indicating that HMGB2 could partially compensate for the loss of HMGB1 in the cell (48). The possible functional redundancy of HMGB1 and HMGB2 (at least in some biological processes) may also explain our finding that the double knock-down of HMGB1 and HMGB2 in pRb-negative cells was necessary in order to observe a significant decrease in cellular levels of topoisomerase IIalpha. However, as we have not succeeded in silencing of HMGB2 expression only and/or without concomitant silencing of HMGB1 expression (using various shRNA constructs directed against different parts of hHMGB2 mRNA, unpublished results) we could not determine the exact contribution of the individual HMGB-type proteins to the cellular expression of topo IIalpha.
###end p 74
###begin p 75
###xml 73 74 61 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 265 266 253 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 267 269 255 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48">48</xref>
###xml 331 334 319 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">not</italic>
###xml 447 449 431 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B52">52</xref>
###xml 450 452 434 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B53">53</xref>
###xml 539 541 523 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B54">54</xref>
###xml 573 584 557 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topoII&#945;</italic>
###xml 735 746 715 722 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topoII&#945;</italic>
###xml 875 877 847 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 878 880 850 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 881 883 853 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 944 956 916 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 1099 1101 1067 1069 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 1102 1104 1070 1072 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 1105 1107 1073 1075 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B55">55</xref>
###xml 1185 1197 1153 1161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 567 572 <span type="species:ncbi:9606">human</span>
HMGB1 is an abundant and most mobile nuclear protein (approximately1 x 106 molecules per nucleus), but despite its abundance the protein may be limiting within cells as evident from transient over-expression of HMGB1 resulting in transactivation of numerous genes (5,48). Previous transfection experiments revealed that HMGB1, but not HMGB1 lacking the acidic C-tail (HMGB1-DeltaC), could stimulate the Gal4VP16-mediated reporter gene expression (52,53), or the p53-dependent transactivation of the p53-responsive promoter in H1299 cells (54). Transactivation of the human topoIIalpha gene promoter by HMGB1 did not require the acidic C-tail of HMGB1 suggesting that the C-tail did not function as an activator of transcription of the topoIIalpha promoter (this article). Higher DNA binding and/or bending/looping by HMGB1-DeltaC relative to the full-length HMGB1 [see also (14,18,35)] may explain why the truncated HMGB1 protein activated the topo IIalpha gene promoter more efficiently than the full-length HMGB1. Thus, shielding of positively charged A+B di-domain of HMGB1 by the acidic C-tail (13,14,55) may account for lower ability of the full-length protein to up-regulate the topo IIalpha gene promoter.
###end p 75
###begin p 76
###xml 153 155 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 159 161 159 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B56">56</xref>
###xml 274 286 274 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 531 533 523 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B56">56</xref>
###xml 617 619 609 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B56">56</xref>
###xml 688 700 680 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 947 948 935 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 949 951 937 939 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 1074 1076 1062 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 1230 1242 1218 1226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 1247 1258 1231 1239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#946;</italic>
###xml 1271 1273 1252 1254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 1274 1276 1255 1257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B49">49</xref>
###xml 1277 1279 1258 1260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B50">50</xref>
###xml 1280 1282 1261 1263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B51">51</xref>
###xml 1283 1285 1264 1266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B58">58</xref>
###xml 1360 1372 1341 1349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 1382 1389 1359 1366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 2092 2093 2069 2070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 2094 2095 2071 2072 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 2096 2098 2073 2075 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 2261 2273 2238 2246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 2504 2516 2477 2485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 2730 2742 2699 2707 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 2862 2870 2827 2835 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 2946 2958 2911 2919 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 3142 3154 3103 3111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 52 57 <span type="species:ncbi:9606">human</span>
###xml 1224 1229 <span type="species:ncbi:9606">human</span>
We have demonstrated that intercalating residues of human HMGB1 (Phe 38 and Phe 103)-that were essential for the ability of HMGB1 to bend DNA [see also (12,33,34,56)]-were required for the ability of HMGB1 to enhance binding of NF-Y to ICEs and for the up-regulation of the topo IIalpha gene promoter (this article). Interestingly, the intercalating residues of HMGB1 proved to be dispensable for protein-protein interactions such as binding of HMGB1 to topoisomerase IIalpha (11 and unpublished results) or progesterone receptor (56), as well as for a specific binding of progesterone receptor to its cognate sites (56). The mechanism by which HMGB1/2 proteins stimulate activity of the topo IIalpha promoter most likely involves enhancement of transcription factors binding, possibly by pre-bending of the DNA promoter sequences. Numerous transcription factors have been reported to interact with HMGB1 and/or HMGB2, including TBP, Oct and Sp1 (8,27). Binding of NF-Y to short DNA duplexes containing ICEs1-4-binding sites (this article), as well as Oct-1/2 (74) and Sp1 (20) to their DNA cognate sites was enhanced by HMGB1. NF-Y, Sp1 and ICBP90 have previously been shown to be required for efficient transcription from human topo IIalpha and topo IIbeta promoters [(23,49,50,51,58) and refs therein). The ability of HMGB1/2 to enhance NF-Y binding to the topo IIalpha promoter in vivo was to be explained by HMGB1-(NF-Y) interactions, and possibly also by HMGB1-mediated DNA pre-bending of the DNA-binding sites for NF-Y. The fact that no ternary HMGB1-(NF-Y)-DNA complex was detected did not necessarily mean the lack of existence of such a complex. It is possible that HMGB1 could 'deliver' NF-Y to its DNA-binding site by forming a ternary complex which is transient and unstable. This idea is in agreement with previous reports demonstrating the ability of HMGB1 to enhance binding a plethora of sequence-specific proteins to their cognate DNA sites without formation of ternary complexes, despite the detection of the corresponding protein-HMGB1 interactions in 'pull-down' assays (5,8,11). The existence of interactions of pRb with NF-Y (and also with HMGB1) may constitute a basis for understanding of pRb-mediated inhibition of the activity of the topo IIalpha promoter. The observed decrease in binding of NF-Y to ICEs by pRb, as well as inhibition of the ability of HMGB1 to promote binding of NF-Y binding to ICEs (this report), suggested that pRb could down-regulate the activity of the topo IIalpha promoter by preventing NF-Y binding to inverted CCAAT elements. The exact nature of the interactions involving NF-Y, HMGB1, pRb (phosphorylated or non-phosphorylated?) as well as other binding partners on the the topo IIalpha promoter is unknown. In addition, interaction of HMGB1 to NF-Y, as well as stimulation of NF-Y binding to several ICEs in vitro, may also explain our finding that sequential deletion of ICEs5-3 from the topo IIalpha promoter had very little effect on the ability of HMGB1 to up-regulate the promoter. Thus, our results could indicate possible functional redundancy of ICEs for the activation of the topo IIalpha promoter by HMGB1.
###end p 76
###begin p 77
###xml 109 121 109 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 298 310 294 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 422 434 414 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 680 692 668 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 828 840 812 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 1010 1022 990 998 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 1091 1093 1067 1069 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 1179 1191 1155 1163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 103 108 <span type="species:ncbi:9606">human</span>
###xml 292 297 <span type="species:ncbi:9606">human</span>
Results of this article demonstrated that HMGB1 and HMGB2 proteins could significantly up-regulate the human topo IIalpha gene promoter only in cells lacking functional retinoblastoma protein pRb. The exact reason for the inability of HMGB1/2 to significantly up-regulate the activity of the human topo IIalpha gene promoter in pRb-positive cells is unknown. However, the detectable (albeit slight) transactivation of the topo IIalpha promoter in pRb-positive cells could be related to weakening of the inhibitory effect of pRb on the promoter. This could be due to HMGB1 binding to pRb which could partially counteract the inhibitory effect of pRb on NF-Y binding to ICEs of the topo IIalpha promoter (see also the above paragraph). On the other hand, the fact that HMGB1 could significantly (>10-fold) enhance activity of the topo IIalpha promoter in Saos-2 cells transiently expressing mutant pRb (within the A/B pocket) was most likely related to the inability of the mutant to inhibit the activity of the topo IIalpha promoter, rather than to the pRb(mut)-HMGB1 interactions [see also (43)]. The possibility that the failure of the pRb mutant to inhibit the activity of the topo IIalpha promoter was related to the inability of the mutant to interfere with NF-Y binding to ICEs remains to be investigated.
###end p 77
###begin p 78
###xml 71 83 71 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 169 181 165 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 197 199 189 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 332 334 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 335 337 327 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
###xml 536 538 528 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 539 541 531 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B59">59</xref>
###xml 653 665 645 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 690 692 678 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 693 695 681 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 696 698 684 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 699 701 687 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B60">60</xref>
###xml 792 794 776 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
###xml 858 860 842 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 953 965 937 945 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 1027 1029 1007 1009 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 1122 1134 1102 1110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 1182 1190 1154 1162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
###xml 1192 1201 1164 1173 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 7.</label>
###xml 1233 1245 1205 1213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 1377 1389 1341 1349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 1524 1536 1484 1492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 1676 1688 1632 1640 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 2005 2013 1953 1961 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 2073 2085 2021 2029 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 2121 2123 2065 2067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 2124 2126 2068 2070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 2208 2210 2148 2150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 2246 2248 2186 2188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
###xml 1201 2250 1173 2190 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="79">Modulation of activity of human <italic>topo II&#945;</italic> gene and topoisomerase II&#945; by pRb and HMGB1/2 (a hypothesis). HMGB1 and HMGB2 proteins up-regulate the expression of the human <italic>topo II&#945;</italic> gene in pRb-negative cells by enhancement of binding of transcription factor NF-Y to its specific DNA-binding sites (ICEs) within the <italic>topo II&#945;</italic> gene promoter. Binding of NF-Y to the ICEs is facilitated by pre-bending the DNA sequences by HMGB1/2. pRb can inhibit the activity of the <italic>topo II&#945;</italic> gene, as well as the ability of HMGB1 to up-regulate the gene, possibly by reducing binding of NF-Y to ICEs (this article). HMGB1/2 promote cellular expression of topoisomerase II&#945; (this article), and the proteins have also the potential of enhancing catalytic activity of the enzyme, as previously demonstrated <italic>in vitro</italic> (11 and unpublished results). p53 inhibits activity of the <italic>topo II&#945;</italic> gene by compromising NF-Y binding (<xref ref-type="bibr" rid="B24">24</xref>,<xref ref-type="bibr" rid="B45">45</xref>). Unlike the inhibitory effect of pRb on the catalytic activity of topo II&#945; (<xref ref-type="bibr" rid="B22">22</xref>), the enzyme is stimulated by p53 (<xref ref-type="bibr" rid="B46">46</xref>).</p>
###xml 1201 2250 1173 2190 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="79">Modulation of activity of human <italic>topo II&#945;</italic> gene and topoisomerase II&#945; by pRb and HMGB1/2 (a hypothesis). HMGB1 and HMGB2 proteins up-regulate the expression of the human <italic>topo II&#945;</italic> gene in pRb-negative cells by enhancement of binding of transcription factor NF-Y to its specific DNA-binding sites (ICEs) within the <italic>topo II&#945;</italic> gene promoter. Binding of NF-Y to the ICEs is facilitated by pre-bending the DNA sequences by HMGB1/2. pRb can inhibit the activity of the <italic>topo II&#945;</italic> gene, as well as the ability of HMGB1 to up-regulate the gene, possibly by reducing binding of NF-Y to ICEs (this article). HMGB1/2 promote cellular expression of topoisomerase II&#945; (this article), and the proteins have also the potential of enhancing catalytic activity of the enzyme, as previously demonstrated <italic>in vitro</italic> (11 and unpublished results). p53 inhibits activity of the <italic>topo II&#945;</italic> gene by compromising NF-Y binding (<xref ref-type="bibr" rid="B24">24</xref>,<xref ref-type="bibr" rid="B45">45</xref>). Unlike the inhibitory effect of pRb on the catalytic activity of topo II&#945; (<xref ref-type="bibr" rid="B22">22</xref>), the enzyme is stimulated by p53 (<xref ref-type="bibr" rid="B46">46</xref>).</p></caption>
###xml 2250 2250 2190 2190 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkp067f7"/>
###xml 1192 2250 1164 2190 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F7" position="float"><label>Figure 7.</label><caption><p textid="79">Modulation of activity of human <italic>topo II&#945;</italic> gene and topoisomerase II&#945; by pRb and HMGB1/2 (a hypothesis). HMGB1 and HMGB2 proteins up-regulate the expression of the human <italic>topo II&#945;</italic> gene in pRb-negative cells by enhancement of binding of transcription factor NF-Y to its specific DNA-binding sites (ICEs) within the <italic>topo II&#945;</italic> gene promoter. Binding of NF-Y to the ICEs is facilitated by pre-bending the DNA sequences by HMGB1/2. pRb can inhibit the activity of the <italic>topo II&#945;</italic> gene, as well as the ability of HMGB1 to up-regulate the gene, possibly by reducing binding of NF-Y to ICEs (this article). HMGB1/2 promote cellular expression of topoisomerase II&#945; (this article), and the proteins have also the potential of enhancing catalytic activity of the enzyme, as previously demonstrated <italic>in vitro</italic> (11 and unpublished results). p53 inhibits activity of the <italic>topo II&#945;</italic> gene by compromising NF-Y binding (<xref ref-type="bibr" rid="B24">24</xref>,<xref ref-type="bibr" rid="B45">45</xref>). Unlike the inhibitory effect of pRb on the catalytic activity of topo II&#945; (<xref ref-type="bibr" rid="B22">22</xref>), the enzyme is stimulated by p53 (<xref ref-type="bibr" rid="B46">46</xref>).</p></caption><graphic xlink:href="gkp067f7"/></fig>
###xml 163 168 <span type="species:ncbi:9606">human</span>
###xml 1227 1232 <span type="species:ncbi:9606">human</span>
###xml 1371 1376 <span type="species:ncbi:9606">human</span>
Previous reports indicated that p53 could also inhibit activity of the topo IIalpha gene promoter despite the lack of clear consensus p53-binding sites within the human topo IIalpha gene promoter (26). This inhibition was explained as consequence of an interference of p53 with NF-Y binding to regulatory sequences of the promoter (25,46). HMGB1 and HMGB2 proteins have previously been reported to promote binding of p53 (or its close relative, p73) to their specific DNA-binding sites by bending and specific p53-HMGB1/2 interactions (20,59). Whether the latter interactions could counteract or even enhance the reported p53-mediated inhibition of the topo IIalpha gene promoter activity (20,24,45,60) is unclear. Interestingly, the catalytic activity of topo IIalpha was stimulated by p53 (46), albeit by a mechanism different from that reported by HMGB1 (11). Contrary to the action of pRb or p53, the HMGB-type proteins could both transactivate the topo IIalpha promoter and stimulate the catalytic activity of the enzyme (11). A possible mechanism summarizing interplay of pRb, p53 and HMGB1/2 on the activity of the topo IIalpha gene and topoisomerase IIalpha, is outlined in Figure 7. Figure 7.Modulation of activity of human topo IIalpha gene and topoisomerase IIalpha by pRb and HMGB1/2 (a hypothesis). HMGB1 and HMGB2 proteins up-regulate the expression of the human topo IIalpha gene in pRb-negative cells by enhancement of binding of transcription factor NF-Y to its specific DNA-binding sites (ICEs) within the topo IIalpha gene promoter. Binding of NF-Y to the ICEs is facilitated by pre-bending the DNA sequences by HMGB1/2. pRb can inhibit the activity of the topo IIalpha gene, as well as the ability of HMGB1 to up-regulate the gene, possibly by reducing binding of NF-Y to ICEs (this article). HMGB1/2 promote cellular expression of topoisomerase IIalpha (this article), and the proteins have also the potential of enhancing catalytic activity of the enzyme, as previously demonstrated in vitro (11 and unpublished results). p53 inhibits activity of the topo IIalpha gene by compromising NF-Y binding (24,45). Unlike the inhibitory effect of pRb on the catalytic activity of topo IIalpha (22), the enzyme is stimulated by p53 (46).
###end p 78
###begin p 79
###xml 32 44 32 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 176 188 168 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 323 335 311 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 475 487 459 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 804 812 780 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 872 884 848 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 920 922 892 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 923 925 895 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 1007 1009 975 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 1045 1047 1013 1015 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
###xml 26 31 <span type="species:ncbi:9606">human</span>
###xml 170 175 <span type="species:ncbi:9606">human</span>
Modulation of activity of human topo IIalpha gene and topoisomerase IIalpha by pRb and HMGB1/2 (a hypothesis). HMGB1 and HMGB2 proteins up-regulate the expression of the human topo IIalpha gene in pRb-negative cells by enhancement of binding of transcription factor NF-Y to its specific DNA-binding sites (ICEs) within the topo IIalpha gene promoter. Binding of NF-Y to the ICEs is facilitated by pre-bending the DNA sequences by HMGB1/2. pRb can inhibit the activity of the topo IIalpha gene, as well as the ability of HMGB1 to up-regulate the gene, possibly by reducing binding of NF-Y to ICEs (this article). HMGB1/2 promote cellular expression of topoisomerase IIalpha (this article), and the proteins have also the potential of enhancing catalytic activity of the enzyme, as previously demonstrated in vitro (11 and unpublished results). p53 inhibits activity of the topo IIalpha gene by compromising NF-Y binding (24,45). Unlike the inhibitory effect of pRb on the catalytic activity of topo IIalpha (22), the enzyme is stimulated by p53 (46).
###end p 79
###begin p 80
###xml 132 134 125 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B61">61</xref>
###xml 135 137 128 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B62">62</xref>
###xml 172 184 165 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 304 315 293 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#946;</italic>
###xml 369 371 355 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B49">49</xref>
###xml 438 441 424 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1 B2 B3 B4">1&#8211;4</xref>
###xml 663 675 649 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#945;</italic>
###xml 680 691 662 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#946;</italic>
###xml 784 795 763 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#946;</italic>
###xml 166 171 <span type="species:ncbi:9606">human</span>
###xml 298 303 <span type="species:ncbi:9606">human</span>
The two isoforms of topoisomerase II, alpha and beta, are encoded by distinct genes on chromosomes 17q21-22 and 3p24, respectively (61,62). While the activity of the human topo IIalpha gene promoter is low in resting cells and enhanced during proliferation (such as in tumors), the activity of the human topo IIbeta gene promoter is constant throughout the cell cycle (49). Both isoforms differ in their production during the cell cycle (1-4), but they exhibit very similar catalytic activities, including the sensitivity to anticancer drugs specifically targeting topo II. The latter may be interesting in the view of our finding that the activities of both the topo IIalpha and topo IIbeta gene promoters were up-regulated by HMGB1/2. Whether the HMGB1/2-mediated activation of the topo IIbeta gene promoter is also affected by pRb, awaits further investigation.
###end p 80
###begin p 81
###xml 86 87 86 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 273 274 273 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 275 276 275 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 277 279 277 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 280 282 280 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B63">63</xref>
###xml 508 510 508 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B64">64</xref>
###xml 136 141 <span type="species:ncbi:9606">human</span>
Although HMGB1 is expressed throughout the cell cycle with no significant variations (5), the protein is clearly over-expressed in most human tumors, including breast carcinoma, melanoma, gastrointestinal stromal tumors, colon carcinomas and acute myeloblastic leukaemia [(5,8,17,63) and references herein]. HMGB1 over-expression has also been observed upon administration of hormones (estrogen and/or progesterone), resulting in increased potency of anticancer drugs cisplatin and its analogue carboplatin (64). Recently HMGB2 was also found to be over-expressed in cancer (; Gene Expression Atlas, 38065_at).
###end p 81
###begin p 82
###xml 55 60 55 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TOP2A</italic>
###xml 101 103 97 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B65">65</xref>
###xml 104 106 100 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B66">66</xref>
###xml 135 140 131 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TOP2A</italic>
###xml 242 244 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B67">67</xref>
###xml 245 247 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B68">68</xref>
###xml 377 379 365 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B66">66</xref>
###xml 526 528 510 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B69">69</xref>
###xml 529 531 513 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B70">70</xref>
###xml 640 642 620 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 757 759 737 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 998 1005 974 981 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HMGB1/2</italic>
###xml 1151 1156 1127 1132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HMGB1</italic>
###xml 1200 1205 1176 1181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HMGB1</italic>
###xml 1221 1223 1197 1199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B71">71</xref>
###xml 1408 1410 1384 1386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B72">72</xref>
###xml 1464 1466 1440 1442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 1548 1553 1524 1529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HMGB1</italic>
###xml 1592 1593 1568 1569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 1594 1596 1570 1572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B73">73</xref>
###xml 12 17 <span type="species:ncbi:9606">human</span>
###xml 816 824 <span type="species:ncbi:9606">patients</span>
###xml 1429 1437 <span type="species:ncbi:9606">patients</span>
Most of the human tumors have excess DNA copies of the TOP2A (encoding topoisomerase IIalpha) gene [(65,66) and refs therein], and the TOP2A gene amplification may explain the significantly enhanced cellular levels of topo IIalpha in tumors (67,68). Topo IIalpha over-expression has been reported to be associated with poor cancer-specific survival and presence of metastases (66). Up-regulation of topo IIalpha could significantly affect responsiveness of tumors to drugs specifically targeting the enzyme (topo II poisons) (69,70). The fact that the HMGB1/2-mediated up-regulation of cellular levels of topo IIalpha was most prominent in Rb-minus cells (this article) raises the question of a possible relevance of simultaneous HMGB1/2 overexpression and Rb deletions in tumors in respect to clinical prognosis of patients treated with topo II poisons. While over-expression of HMGB1/2 proteins could enhance cellular levels (and/or activity) of topo IIalpha, reduced transcriptional activity of HMGB1/2 genes could diminish the cellular levels (and/or activity) of the enzyme. Several polymorphisms and/or mutations were recently identified in the HMGB1 gene with a potential regulatory impact on HMGB1 transcription (71). In this respect, the B-cell chronic lymphocytic leukemia (B-CLL), a malignant disease with highly variable clinical course, could be of interest due to deletions of the 13q14 locus (72). About 30-50% of patients with 13q14 deletions bear Rb deletions (some of them even biallelic, unpublished results). Interestingly, the HMGB1 gene is localized in the 13q12 locus (5,73). Furthermore, research is necessary to fully understand the involvement of HMGB-type proteins and their possible interplay with tumor suppressor proteins, pRb and p53, in modulation of cellular activity of topo IIalpha.
###end p 82
###begin title 83
FUNDING
###end title 83
###begin p 84
This research was supported by grants to M.S. by the Grant Agency of the Czech Republic (204/08/1530), the Grant Agency of the Academy of Sciences of the Czech Republic (IAA400040702), and by the Academy of Sciences of the Czech Republic (grants no AV0Z50040507 and AV0Z50040702). S.P. was supported by grant IGA MZ CR NR/9293-3. Funding for open access charge: GA CR 204/08/1530 and GA AS CR (IAA400040702).
###end p 84
###begin p 85
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of interest statement</italic>
Conflict of interest statement. None declared
###end p 85
###begin title 86
ACKNOWLEDGEMENTS
###end title 86
###begin p 87
###xml 1337 1348 1321 1329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">topo II&#946;</italic>
###xml 501 506 <span type="species:ncbi:9606">human</span>
###xml 585 590 <span type="species:ncbi:9606">human</span>
###xml 921 926 <span type="species:ncbi:9606">human</span>
###xml 1331 1336 <span type="species:ncbi:9606">human</span>
We greatly appreciate the gifts of the following materials: stable Saos-2 derivatives expressing pRb under the tetracycline regulated promoter from Liang Zhu (Department Developmental and Molecular Biology, Albert Einstein College of Medicine, New York, USA); alpha-NF-YB antibodies from Roberto Mantovani (Dipartimento di Scienze Biomolecolari e Biotecnologie, Universita di Milano, Milano, Italy); pcDNA-Zeo(-)-U6 contructs expressing specific shRNAs for silencing of HMGB1 or HMGB1/2 expression in human cells from Stephen J. Lippard (Department of Chemistry, MIT, Cambridge, USA); human wild-type and mutant pRb in pCMV vector from Pradip Raychaudhuri (Department of Biochemistry, College of Medicine, University of Illinois, Chicago, USA); plasmids encoding GST-fused wild-type pRb and mutant pRb from Sybille Mittnacht (Institute of Cancer Research, Chester Beatty Labs, London, UK); plasmid pRSET(his-Rb) encoding human wild-type His-pRb was kindly provided by Ronen Marmorstein (The Wistar Institute, Philadelphia, USA); plasmids pTIIalpha-617 and pTIIalpha-617(ICE2mt) from Kathryn M. Stowell (Institute of Molecular BioSciences, Palmerston North, New Zealand); plasmid pTIIalpha-557 and its truncated forms from Parker D. Suttle (Department of Pharmacology, College of Medicine, University of Tennessee, Tennessee, USA); human topo IIbeta gene promoter plasmid construct from Susan P.C. Colle (Queen's University, Cancer Research Institute, Division of Cancer Biology & Genetics, Kingston, Canada). A skilful assistance of Alena Bacikova and Lucia Gulasova in some experiments is greatly appreciated. We also thank Lenka Jurackova for excellent technical assistance, Jitka Malcikova for QRT-PCR results evaluation, and Francois Strauss (Universite Pierre et Marie Curie, Paris) for critical reading of the manuscript and many helpful suggestions.
###end p 87
###begin title 88
REFERENCES
###end title 88
###begin article-title 89
Cellular roles of DNA topoisomerases: a molecular perspective
###end article-title 89
###begin article-title 90
Catalytic function of DNA topoisomerase II
###end article-title 90
###begin article-title 91
Etoposide, topoisomerase II and cancer
###end article-title 91
###begin article-title 92
Emerging DNA topoisomerase inhibitors as anticancer drugs
###end article-title 92
###begin article-title 93
The HMG-box: a versatile protein domain occurring in a wide variety of DNA-binding proteins
###end article-title 93
###begin article-title 94
Significant (re)location: how to use chromatin and/or abundant proteins as messages of life and death
###end article-title 94
###begin article-title 95
HMG1 and 2, and related 'architectural' DNA-binding proteins
###end article-title 95
###begin article-title 96
HMGB proteins and gene expression
###end article-title 96
###begin article-title 97
The nonspecific DNA-binding and -bending proteins HMG1 and HMG2 promote the assembly of complex nucleoprotein structures
###end article-title 97
###begin article-title 98
High-mobility-group 1 protein mediates DNA bending as determined by ring closures
###end article-title 98
###begin article-title 99
###xml 21 26 <span type="species:ncbi:9606">human</span>
HMGB1 interacts with human topoisomerase IIalpha and stimulates its catalytic activity
###end article-title 99
###begin article-title 100
Determinants of specific binding of HMGB1 protein to hemicatenated DNA loops
###end article-title 100
###begin article-title 101
The specific interactions of HMG 1 and 2 with negatively supercoiled DNA are modulated by their acidic C-terminal domains and involve cysteine residues in their HMG 1/2 boxes
###end article-title 101
###begin article-title 102
DNA looping by the HMG-box domains of HMG1 and modulation of DNA binding by the acidic C-terminal domain
###end article-title 102
###begin article-title 103
###xml 109 113 <span type="species:ncbi:10090">mice</span>
The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice
###end article-title 103
###begin article-title 104
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast Nhp6A/B and mammalian Hmgb1 facilitate the maintenance of genome stability
###end article-title 104
###begin article-title 105
###xml 134 139 <span type="species:ncbi:9606">human</span>
Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas
###end article-title 105
###begin article-title 106
Chromatin immunoprecipitation (ChIP) on chip experiments uncover a widespread distribution of NF-Y binding CCAAT sites outside of core promoters
###end article-title 106
###begin article-title 107
DNA bending by the chromosomal protein HMG1 and its high mobility group box domains. Effect of flanking sequences
###end article-title 107
###begin article-title 108
###xml 118 123 <span type="species:ncbi:9606">human</span>
HMGB1 and HMGB2 cell-specifically down-regulate the p53- and p73-dependent sequence-specific transactivation from the human Bax gene promoter
###end article-title 108
###begin article-title 109
pRB and p107 have distinct effects when expressed in pRB-deficient tumor cells at physiologically relevant levels
###end article-title 109
###begin article-title 110
###xml 31 36 <span type="species:ncbi:9606">human</span>
Functional interaction between human topoisomerase IIalpha and retinoblastoma protein
###end article-title 110
###begin article-title 111
Modulation of DNA topoisomerase IIalpha promoter activity by members of the Sp (specificity protein) and NF-Y (nuclear factor Y) families of transcription factors
###end article-title 111
###begin article-title 112
Inhibition of DNA topoisomerase IIalpha gene expression by the p53 tumor suppressor
###end article-title 112
###begin article-title 113
###xml 106 111 <span type="species:ncbi:9606">human</span>
Induction of low density lipoprotein receptor and a transcription factor SP-1 by tumor necrosis factor in human microvascular endothelial cells
###end article-title 113
###begin article-title 114
###xml 34 39 <span type="species:ncbi:9606">human</span>
Transcriptional regulation of the human topoisomerase IIalpha gene
###end article-title 114
###begin article-title 115
The binding interaction of HMG-1 with the TATA-binding protein/TATA complex
###end article-title 115
###begin article-title 116
HMGB1 interacts with many apparently unrelated proteins by recognizing short amino acid sequences
###end article-title 116
###begin article-title 117
The molecular biology of the CCAAT-binding factor NF-Y
###end article-title 117
###begin article-title 118
###xml 74 79 <span type="species:ncbi:9606">human</span>
Evaluation of a potential regulatory role for inverted CCAAT boxes in the human topoisomerase IIalpha promoter
###end article-title 118
###begin article-title 119
###xml 18 23 <span type="species:ncbi:9606">human</span>
Regulation of the human topoisomerase IIalpha gene promoter in confluence-arrested cells
###end article-title 119
###begin article-title 120
###xml 37 42 <span type="species:ncbi:9606">human</span>
Role of an inverted CCAAT element in human topoisomerase IIalpha gene expression in ICRF-187-sensitive and -resistant CEM leukemic cells
###end article-title 120
###begin article-title 121
###xml 41 65 41 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae</italic>
###xml 41 65 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Binding to cisplatin-modified DNA by the Saccharomyces cerevisiae HMGB protein Nhp6A
###end article-title 121
###begin article-title 122
The role of intercalating residues in chromosomal high-mobility-group protein DNA binding, bending and specificity
###end article-title 122
###begin article-title 123
Differences in the DNA-binding properties of the HMG-box domains of HMG1 and the sex-determining factor SRY
###end article-title 123
###begin article-title 124
DNA-binding properties of the tandem HMG boxes of high-mobility-group protein 1 (HMG1)
###end article-title 124
###begin article-title 125
Two mutations of basic residues within the N-terminus of HMG-1 B domain with different effects on DNA supercoiling and binding to bent DNA
###end article-title 125
###begin article-title 126
Intercalating residues determine the mode of HMGB1 domains A and B binding to cisplatin-modified DNA
###end article-title 126
###begin article-title 127
Nature of full-length HMGB1 binding to cisplatin-modified DNA
###end article-title 127
###begin article-title 128
The retinoblastoma protein and cell cycle control
###end article-title 128
###begin article-title 129
The retinoblastoma tumor supressor protein is required for efficient processing and repair of trapped topoisomerase II-DNA-cleavable complexes
###end article-title 129
###begin article-title 130
New roles for the RB tumor supressor protein
###end article-title 130
###begin article-title 131
Growth suppression and radiosensitivity increase by HMGB1 in breast cancer
###end article-title 131
###begin article-title 132
siRNA-mediated gene silencing: a global genome view
###end article-title 132
###begin article-title 133
###xml 42 47 <span type="species:ncbi:9606">human</span>
p53 regulates the minimal promoter of the human topoisomerase IIalpha gene
###end article-title 133
###begin article-title 134
###xml 61 66 <span type="species:ncbi:9606">human</span>
The p53 tumor supressor stimulates the catalytic activity of human topoisomerase IIalpha by enhancing the rate of ATP hydrolysis
###end article-title 134
###begin article-title 135
###xml 49 53 <span type="species:ncbi:10090">mice</span>
Reduced fertility and spermatogenesis defects in mice lacking chromosomal protein Hmgb2
###end article-title 135
###begin article-title 136
HMG proteins: dynamic players in gene regulation and differentiation
###end article-title 136
###begin article-title 137
###xml 24 29 <span type="species:ncbi:9606">human</span>
Characterization of the human topoisomerase IIbeta (TOP2B) promoter activity: essential roles of the nuclear factor-Y (NF-Y)- and specificity protein-1 (Sp1)-binding sites
###end article-title 137
###begin article-title 138
###xml 56 59 <span type="species:ncbi:10116">rat</span>
Sp1 mediates cell proliferation-dependent regulation of rat DNA topoisomerase IIalpha gene promoter
###end article-title 138
###begin article-title 139
Overexpression of ICBP90, a novel CCAAT-binding protein, overcomes cell contact inhibition by forcing topoisomerase II alpha expression
###end article-title 139
###begin article-title 140
Stimulation of transcription in cultured cells by high mobility group protein 1: essential role of the acidic carboxyl-terminal region
###end article-title 140
###begin article-title 141
Acidic C-tail of HMGB1 is required for its target binding to nucleosome linker DNA and transciption stimulation
###end article-title 141
###begin article-title 142
The acidic C-terminal domain and A-box of HMGB-1 regulates p53-mediated transcription
###end article-title 142
###begin article-title 143
Mapping intramolecular interactions between domains in HMGB1 using a tail-truncation approach
###end article-title 143
###begin article-title 144
Mechanism of high-mobility group protein B enhancement of progesterone receptor sequence-specific DNA binding
###end article-title 144
###begin article-title 145
Cytotoxic signalling by inhibitors of DNA topoisomerase II
###end article-title 145
###begin article-title 146
The retinoblastoma gene and its product are targeted by ICBP90: a key mechanism in the G1/S transition during the cell cycle
###end article-title 146
###begin article-title 147
High mobility group protein-1 (HMG-1) is a unique activator of p53
###end article-title 147
###begin article-title 148
###xml 116 124 <span type="species:ncbi:9606">patients</span>
Topoisomerase II alpha gene expression is regulated by the p53 tumor supressor gene in nonsmall cell lung carcinoma patients
###end article-title 148
###begin article-title 149
###xml 40 45 <span type="species:ncbi:9606">human</span>
Cloning and sequencing of cDNA encoding human DNA topoisomerase II and localization of the gene to chromosome region 17q21-22
###end article-title 149
###begin article-title 150
###xml 54 59 <span type="species:ncbi:9606">human</span>
Isolation of cDNA clones encoding the beta isozyme of human DNA topoisomerase II and localisation of the gene to chromosome 3p24
###end article-title 150
###begin article-title 151
###xml 29 34 <span type="species:ncbi:4932">yeast</span>
###xml 86 91 <span type="species:ncbi:9606">human</span>
HMGB1 inhibits cell death in yeast and mammalian cells and is abundantly expressed in human breast carcinoma
###end article-title 151
###begin article-title 152
Steroid hormones induce HMG1 overexpression and sensitize breast cancer cells to cisplatin and carboplatin
###end article-title 152
###begin article-title 153
Upregulation of topoisomerase IIalpha expression in advanced gallbladder carcinoma: a potential chemotherapeutic target
###end article-title 153
###begin article-title 154
Topoisomerase IIalpha gene (TOP2A) amplification and deletion in cancer - more common than anticipated
###end article-title 154
###begin article-title 155
(March 14, 2008) Gene expression of topoisomerase II alpha (TOP2A) by microarray analysis is highly prognostic in estrogen receptor (ER) positive breast cancer
###end article-title 155
###begin article-title 156
Modification of topoisomerase genes copy number in newly diagnosed childhood acute lymphoblastic leukemia
###end article-title 156
###begin article-title 157
HER-2 and topoisomerase II as predictors of response to chemotherapy
###end article-title 157
###begin article-title 158
Topoisomerase II alpha amplification may predict benefit from adjuvant anthracyclines in HER2 positive early breast cancer
###end article-title 158
###begin article-title 159
###xml 29 34 <span type="species:ncbi:9606">human</span>
The genetic variation of the human HMGB1 gene
###end article-title 159
###begin article-title 160
Genomic aberrations and survival in chronic lymphocytic leukemia
###end article-title 160
###begin article-title 161
###xml 29 34 <span type="species:ncbi:9606">human</span>
The active gene that encodes human high mobility group 1 protein (HMG1) contains introns and maps to chromosome 13
###end article-title 161

